Inflammatory disease
MONDO:0021166A disease involving a pathogenic inflammatory response in the anatomical structure.
Also known as: anatomical structure inflammation, inflammation of anatomical structure, inflammatory disease, inflammatory disorder
10833 clinical trials for this condition and its sub-types, 348 tagged with Inflammatory disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inflammatory disease
-
Arthritic joint disease 194 trials · 2,548 incl. sub-types
13 sub-types
- Osteoarthritis 683 trials · 1,639 incl. sub-types Sub-types →
- Rheumatoid arthritis 576 trials · 795 incl. sub-types Sub-types →
- Juvenile idiopathic arthritis 107 trials · 115 incl. sub-types Sub-types →
- Infective arthritis 25 trials · 100 incl. sub-types Sub-types →
- Synovitis 15 trials Sub-types →
- Adult-onset Still disease 12 trials
- Polyarticular arthritis 11 trials Sub-types →
- Chondrocalcinosis 5 trials · 7 incl. sub-types Sub-types →
- Hemophilic arthropathy 7 trials
- Reactive arthritis 6 trials
- Negative rheumatoid factor polyarthritis 1 trial
- Periarthritis 1 trial Sub-types →
- Transient arthritis 0 trials
-
Dermatitis 65 trials · 1,623 incl. sub-types
33 sub-types
- Atopic eczema 467 trials · 480 incl. sub-types Sub-types →
- Psoriasis 379 trials Sub-types →
- Urticaria 28 trials · 164 incl. sub-types Sub-types →
- Skin infection 12 trials · 152 incl. sub-types Sub-types →
- Dermatomyositis 81 trials · 100 incl. sub-types Sub-types →
- Vitiligo 100 trials Sub-types →
- Acne 91 trials Sub-types →
- Autoimmune bullous skin disease 7 trials · 55 incl. sub-types Sub-types →
- Lichen planus 19 trials · 47 incl. sub-types Sub-types →
- Radiodermatitis 37 trials · 42 incl. sub-types Sub-types →
- Contact dermatitis 9 trials · 24 incl. sub-types Sub-types →
- Lichen sclerosus et atrophicus 10 trials · 20 incl. sub-types Sub-types →
- Seborrheic dermatitis 15 trials Sub-types →
- Neurodermatitis 10 trials
- Folliculitis 1 trial · 8 incl. sub-types Sub-types →
- Cutaneous vasculitis 4 trials · 5 incl. sub-types Sub-types →
- Neurotic excoriation 5 trials
- Acanthosis nigricans 4 trials Sub-types →
- Acneiform dermatitis 4 trials
- Acrodermatitis 0 trials · 2 incl. sub-types Sub-types →
- Hydroa vacciniforme 2 trials Sub-types →
- Acute generalized exanthematous pustulosis 1 trial
- Exfoliative dermatitis 1 trial
- Granuloma annulare 1 trial
- Lipodermatosclerosis 1 trial
- Parapsoriasis 0 trials · 1 incl. sub-types Sub-types →
- Porphyria cutanea tarda 0 trials · 1 incl. sub-types Sub-types →
- Dermatosis papulosa nigra 0 trials
- Food dermatitis 0 trials
- Granulomatous dermatitis 0 trials
- Intertrigo 0 trials
- Pityriasis rosea 0 trials
- Spongiotic dermatitis 0 trials
-
Gastroenteritis 20 trials · 837 incl. sub-types
9 sub-types
- Colitis 41 trials · 677 incl. sub-types Sub-types →
- Appendicitis 76 trials
- Intestinal infectious disease 3 trials · 49 incl. sub-types Sub-types →
- Inflammatory diarrhea 0 trials · 33 incl. sub-types Sub-types →
- Enteritis 5 trials · 23 incl. sub-types Sub-types →
- Eosinophilic gastroenteritis 6 trials · 7 incl. sub-types Sub-types →
- Campylobacteriosis 3 trials Sub-types →
- Intestinal tuberculosis 2 trials
- Salmonella gastroenteritis 0 trials
-
Hepatitis 50 trials · 731 incl. sub-types
9 sub-types
- Viral hepatitis 12 trials · 443 incl. sub-types Sub-types →
- Metabolic dysfunction-associated steatohepatitis 231 trials
- Alcoholic hepatitis 31 trials
- Autoimmune hepatitis 30 trials · 31 incl. sub-types Sub-types →
- Drug-induced hepatitis 3 trials
- Fulminant viral hepatitis 3 trials
- Granulomatous hepatitis 0 trials
- Hepatic tuberculosis 0 trials
- Idiopathic peliosis hepatis 0 trials
-
Pneumonitis 15 trials · 645 incl. sub-types
6 sub-types
- Pneumonia 326 trials · 610 incl. sub-types Sub-types →
- Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types Sub-types →
- Radiation pneumonitis 20 trials
- Aspiration pneumonitis 2 trials Sub-types →
- Ichthyosis prematurity syndrome 1 trial
- Toxic pneumonitis 0 trials
-
Periodontitis 436 trials · 600 incl. sub-types
4 sub-types
- Periapical periodontitis 108 trials · 148 incl. sub-types Sub-types →
- Chronic periodontitis 65 trials · 122 incl. sub-types Sub-types →
- Acute pericementitis 0 trials · 8 incl. sub-types Sub-types →
- Pericoronitis 1 trial
-
Mucositis 22 trials · 552 incl. sub-types
6 sub-types
- Stomatitis 82 trials · 312 incl. sub-types Sub-types →
- Rhinitis 22 trials · 159 incl. sub-types Sub-types →
- Gastrointestinal mucositis 3 trials · 52 incl. sub-types Sub-types →
- Endometritis 5 trials · 10 incl. sub-types Sub-types →
- Tracheitis 2 trials · 7 incl. sub-types Sub-types →
- Epiglottitis 1 trial Sub-types →
-
Nephritis 16 trials · 503 incl. sub-types
4 sub-types
- Glomerulonephritis 33 trials · 456 incl. sub-types Sub-types →
- Hereditary nephritis 17 trials · 152 incl. sub-types Sub-types →
- Pyelitis 0 trials · 21 incl. sub-types Sub-types →
- Interstitial nephritis 6 trials · 9 incl. sub-types Sub-types →
-
Myositis disease 105 trials · 298 incl. sub-types
11 sub-types
- Idiopathic inflammatory myopathy 60 trials · 181 incl. sub-types Sub-types →
- Tendinitis 24 trials · 77 incl. sub-types Sub-types →
- Inclusion body myositis 35 trials · 38 incl. sub-types Sub-types →
- Myositis ossificans 11 trials Sub-types →
- Myositis fibrosa 1 trial
- Bacterial myositis 0 trials Sub-types →
- Fungal myositis 0 trials
- Idiopathic granulomatous myositis 0 trials
- Infectious myositis 0 trials Sub-types →
- Orbital myositis 0 trials
- Viral myositis 0 trials
-
Keratitis 6 trials · 296 incl. sub-types
11 sub-types
- Keratoconjunctivitis 1 trial · 259 incl. sub-types Sub-types →
- Corneal infection 6 trials · 22 incl. sub-types Sub-types →
- Corneal ulcer 16 trials · 18 incl. sub-types Sub-types →
- Corneal neovascularization 4 trials Sub-types →
- Deep keratitis 0 trials · 1 incl. sub-types Sub-types →
- Autosomal dominant keratitis 0 trials
- Filamentary keratitis 0 trials
- Macular keratitis 0 trials
- Photokeratitis 0 trials
- Scleroperikeratitis 0 trials
- Superficial keratitis 0 trials Sub-types →
-
Vasculitis 63 trials · 286 incl. sub-types
18 sub-types
- Necrotizing vasculitis 0 trials · 143 incl. sub-types Sub-types →
- Arteritis 5 trials · 104 incl. sub-types Sub-types →
- Central nervous system vasculitis 3 trials · 55 incl. sub-types Sub-types →
- Phlebitis 13 trials · 21 incl. sub-types Sub-types →
- Immune complex mediated vasculitis 0 trials · 18 incl. sub-types Sub-types →
- Hypersensitivity vasculitis 0 trials · 16 incl. sub-types Sub-types →
- Kawasaki disease 15 trials
- Cutaneous vasculitis 4 trials · 5 incl. sub-types Sub-types →
- Deficiency of adenosine deaminase 2 3 trials
- Retinal vasculitis 2 trials
- Aortitis 1 trial
- Choroiditis 0 trials · 1 incl. sub-types Sub-types →
- Livedoid vasculopathy 1 trial
- Secondary vasculitis 0 trials · 1 incl. sub-types Sub-types →
- Shwartzman phenomenon 0 trials
- Autoimmune vasculitis 0 trials Sub-types →
- Lymphangitis 0 trials
- Vasculitis, lymphocytic, nodular 0 trials
-
Conjunctivitis 6 trials · 286 incl. sub-types
8 sub-types
- Keratoconjunctivitis 1 trial · 259 incl. sub-types Sub-types →
- Chronic conjunctivitis 0 trials · 19 incl. sub-types Sub-types →
- Bacterial conjunctivitis 3 trials Sub-types →
- Blepharoconjunctivitis 2 trials Sub-types →
- Rosacea conjunctivitis 2 trials
- Viral conjunctivitis 1 trial · 2 incl. sub-types Sub-types →
- Acute conjunctivitis 0 trials · 1 incl. sub-types Sub-types →
- Papillary conjunctivitis 0 trials Sub-types →
-
Encephalomyelitis 3 trials · 226 incl. sub-types
7 sub-types
- Encephalitis 25 trials · 95 incl. sub-types Sub-types →
- Meningitis 42 trials · 73 incl. sub-types Sub-types →
- Myelitis 4 trials · 52 incl. sub-types Sub-types →
- Optic neuritis 21 trials · 25 incl. sub-types Sub-types →
- Hypophysitis 2 trials Sub-types →
- Venezuelan equine encephalitis 1 trial
- Cerebritis 0 trials
-
Pancreatitis 120 trials · 203 incl. sub-types
5 sub-types
- Acute pancreatitis 101 trials · 113 incl. sub-types Sub-types →
- Chronic pancreatitis 80 trials · 84 incl. sub-types Sub-types →
- Autoimmune pancreatitis 3 trials Sub-types →
- Thiopurine immunosuppressant-induced pancreatitis 1 trial
- Alcoholic pancreatitis 0 trials
-
Pulpitis 191 trials
-
Cholangitis 17 trials · 139 incl. sub-types
9 sub-types
- Cholecystitis 35 trials · 65 incl. sub-types Sub-types →
- Sclerosing cholangitis 3 trials · 57 incl. sub-types Sub-types →
- Acute cholangitis 7 trials · 42 incl. sub-types Sub-types →
- Autoimmune cholangitis 1 trial
- Ascending cholangitis 0 trials
- Chronic cholangitis 0 trials
- Pericholangitis 0 trials
- Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome 0 trials
- Suppurative cholangitis 0 trials
-
Hidradenitis 21 trials · 135 incl. sub-types
1 sub-type
- Hidradenitis suppurativa 135 trials Sub-types →
-
Sinusitis 44 trials · 130 incl. sub-types
5 sub-types
- Chronic rhinosinusitis 89 trials · 91 incl. sub-types Sub-types →
- Maxillary sinusitis 5 trials · 7 incl. sub-types Sub-types →
- Frontal sinusitis 2 trials Sub-types →
- Ethmoid sinusitis 0 trials Sub-types →
- Sphenoid sinusitis 0 trials Sub-types →
-
Bursitis 111 trials · 119 incl. sub-types
5 sub-types
- Achilles bursitis 7 trials
- Periarthritis 1 trial Sub-types →
- Gonococcal bursitis 0 trials
- Olecranon bursitis 0 trials
- Subacute bursitis 0 trials
-
Spondylitis 8 trials · 119 incl. sub-types
3 sub-types
- Ankylosing spondylitis 109 trials · 113 incl. sub-types Sub-types →
- Gonococcal spondylitis 0 trials
- Inflammatory spondylopathy 0 trials
-
Inflammation of heart layer 1 trial · 114 incl. sub-types
2 sub-types
- Endocarditis 51 trials · 61 incl. sub-types Sub-types →
- Myocarditis 40 trials · 52 incl. sub-types Sub-types →
-
Esophagitis 22 trials · 102 incl. sub-types
6 sub-types
- Eosinophilic esophagitis 67 trials Sub-types →
- Peptic esophagitis 24 trials
- Crohn disease of the esophagus 1 trial
- Bacterial esophagitis 0 trials
- Fungal esophagitis 0 trials Sub-types →
- Viral esophagitis 0 trials
-
Vaginitis 11 trials · 102 incl. sub-types
3 sub-types
- Infective vaginitis 1 trial · 61 incl. sub-types Sub-types →
- Postmenopausal atrophic vaginitis 38 trials
- Vulvovaginitis 3 trials · 27 incl. sub-types Sub-types →
-
Fasciitis 7 trials · 97 incl. sub-types
6 sub-types
- Plantar fasciitis 85 trials
- Necrotizing fasciitis 7 trials
- Eosinophilic fasciitis 1 trial
- Ischemic fasciitis 0 trials
- Nodular fasciitis 0 trials Sub-types →
- Proliferative fasciitis 0 trials
-
Epicondylitis 86 trials
-
Cystitis 12 trials · 72 incl. sub-types
14 sub-types
- Chronic cystitis 10 trials · 50 incl. sub-types Sub-types →
- Radiation cystitis 9 trials
- Acute cystitis 7 trials Sub-types →
- Hemorrhagic cystitis 5 trials
- Trichomonas cystitis 0 trials
- Acalculous cholecystitis 0 trials
- Cystitis cystica 0 trials
- Diphtheritic cystitis 0 trials
- Emphysematous cholecystitis 0 trials
- Eosinophilic cryptitis 0 trials
- Gonococcal cystitis 0 trials Sub-types →
- Prostatocystitis 0 trials
- Pyelocystitis 0 trials
- Trigonitis 0 trials
-
Uveitis 37 trials · 67 incl. sub-types
9 sub-types
- Posterior uveitis 10 trials · 22 incl. sub-types Sub-types →
- Anterior uveitis 8 trials · 20 incl. sub-types Sub-types →
- Panuveitis 6 trials · 9 incl. sub-types Sub-types →
- Intermediate uveitis 8 trials Sub-types →
- Iritis 0 trials · 6 incl. sub-types Sub-types →
- Autoimmune uveitis 2 trials
- Chorioretinitis 2 trials Sub-types →
- Idiopathic posterior uveitis 1 trial
- Suppurative uveitis 0 trials
-
1 sub-type
- Lewis-Sumner syndrome 0 trials
-
Thyroiditis 1 trial · 62 incl. sub-types
3 sub-types
- Autoimmune thyroid disease 8 trials · 62 incl. sub-types Sub-types →
- Acute thyroiditis 0 trials · 2 incl. sub-types Sub-types →
- Suppurative thyroiditis 0 trials
-
Otitis media 39 trials · 60 incl. sub-types
8 sub-types
- Chronic otitis media 10 trials · 28 incl. sub-types Sub-types →
- Infectious otitis media 24 trials
- Non-suppurative otitis media 0 trials · 17 incl. sub-types Sub-types →
- Suppurative otitis media 0 trials · 5 incl. sub-types Sub-types →
- Allergic otitis media 0 trials Sub-types →
- Middle ear cholesterol granuloma 0 trials
- Otosalpingitis 0 trials Sub-types →
- Tympanitis 0 trials Sub-types →
-
Serositis 0 trials · 58 incl. sub-types
4 sub-types
- Peritonitis 15 trials · 34 incl. sub-types Sub-types →
- Synovitis 15 trials Sub-types →
- Pleurisy 2 trials · 9 incl. sub-types Sub-types →
- Parametritis 0 trials
-
Tracheobronchitis 5 trials · 55 incl. sub-types
2 sub-types
- Bronchitis 24 trials · 50 incl. sub-types Sub-types →
- Tracheitis 2 trials · 7 incl. sub-types Sub-types →
-
Gastritis 21 trials · 50 incl. sub-types
16 sub-types
- Chronic gastritis 9 trials · 23 incl. sub-types Sub-types →
- Eosinophilic gastritis 5 trials
- Autoimmune gastritis 3 trials
- Bacterial gastritis 2 trials
- Collagenous gastritis 1 trial
- Gastroduodenal Crohn disease 1 trial
- Alcoholic gastritis 0 trials
- Chronic erosive gastritis 0 trials
- Fungal gastritis 0 trials
- Gastric mucosal hypertrophy 0 trials
- Gastroduodenitis 0 trials
- Granulomatous gastritis 0 trials
- Lymphocytic gastritis 0 trials
- Necrotizing gastritis 0 trials
- Pediatric collagenous gastritis 0 trials
- Viral gastritis 0 trials Sub-types →
-
Pharyngitis 34 trials · 43 incl. sub-types
2 sub-types
- Streptococcal sore throat 8 trials
- Acute pharyngitis 6 trials
-
Ear infection 9 trials · 40 incl. sub-types
5 sub-types
- Infectious otitis media 24 trials
- Otitis externa 3 trials · 12 incl. sub-types Sub-types →
- Geniculate herpes zoster 0 trials
- Infectious otitis interna 0 trials
- Viral labyrinthitis 0 trials
-
Endophthalmitis 9 trials · 38 incl. sub-types
8 sub-types
- Corneal infection 6 trials · 22 incl. sub-types Sub-types →
- Infectious anterior uveitis 5 trials · 6 incl. sub-types Sub-types →
- Parasitic endophthalmitis 0 trials · 5 incl. sub-types Sub-types →
- Cytomegalovirus retinitis 2 trials
- Histoplasmosis retinitis 1 trial
- Purulent endophthalmitis 0 trials · 1 incl. sub-types Sub-types →
- Gonococcal endophthalmia 0 trials Sub-types →
- Infectious posterior uveitis 0 trials
-
Chronic granulomatous disease 37 trials
7 sub-types
- Granulomatous disease, chronic, X-linked 10 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1 3 trials
- Granulomatous disease with defect in neutrophil chemotaxis 0 trials
- Granulomatous disease, chronic, autosomal recessive, 5 0 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative 0 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 0 trials
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 0 trials
-
Nasopharyngitis 6 trials · 37 incl. sub-types
2 sub-types
- Common cold 36 trials
- Adenoiditis 0 trials
-
Diverticulitis 28 trials · 34 incl. sub-types
2 sub-types
- Diverticulitis of colon 18 trials
- Small intestine diverticulitis 0 trials Sub-types →
-
Neuritis 18 trials · 29 incl. sub-types
7 sub-types
- Vestibular neuronitis 9 trials
- Polyneuritis 3 trials
- Brachial plexus neuritis 0 trials Sub-types →
- Mononeuritis simplex 0 trials Sub-types →
- Motor nerve neuritis 0 trials Sub-types →
- Neuritis of upper limb 0 trials Sub-types →
- Neuroretinitis 0 trials
-
Blepharitis 11 trials · 28 incl. sub-types
6 sub-types
- Parasitic eyelid infestation 0 trials · 9 incl. sub-types Sub-types →
- Hordeolum 1 trial · 7 incl. sub-types Sub-types →
- Blepharoconjunctivitis 2 trials Sub-types →
- Noninfectious dermatoses of eyelid 0 trials · 1 incl. sub-types Sub-types →
- Squamous blepharitis 0 trials
- Ulcerative blepharitis 0 trials
-
Tonsillitis 23 trials · 27 incl. sub-types
2 sub-types
- Acute tonsillitis 6 trials
- Adenoiditis 0 trials
-
Vulvitis 0 trials · 27 incl. sub-types
1 sub-type
- Vulvovaginitis 3 trials · 27 incl. sub-types Sub-types →
-
Pericarditis 20 trials · 24 incl. sub-types
6 sub-types
- Dressler syndrome 2 trials
- Constrictive pericarditis 1 trial
- Pericardial tuberculosis 1 trial
- Histoplasma pericarditis 0 trials
- Rheumatic pericarditis 0 trials Sub-types →
- Viral pericarditis 0 trials
-
Lymphadenitis 3 trials · 22 incl. sub-types
10 sub-types
- Kawasaki disease 15 trials
- Cervical lymphadenitis 2 trials Sub-types →
- Cat-scratch disease 1 trial
- Sialadenitis 1 trial Sub-types →
- Kikuchi-Fujimoto disease 0 trials
- Kimura disease 0 trials
- Axillary lymphadenitis 0 trials
- Mesenteric lymphadenitis 0 trials Sub-types →
- Postauricular lymphadenitis 0 trials
- Suppurative lymphadenitis 0 trials
-
Proctitis 2 trials · 21 incl. sub-types
2 sub-types
- Radiation proctitis 13 trials
- Proctocolitis 2 trials · 7 incl. sub-types Sub-types →
-
Neuronitis 20 trials
-
Rheumatic heart disease 17 trials
4 sub-types
- Acute rheumatic heart disease 0 trials
- Rheumatic congestive heart failure 0 trials
- Rheumatic myocarditis 0 trials
- Rheumatic pericarditis 0 trials Sub-types →
-
Periostitis 0 trials · 16 incl. sub-types
2 sub-types
- Alveolar periostitis 16 trials
- Orbital periostitis 0 trials
-
Prostatitis 4 trials · 15 incl. sub-types
5 sub-types
- Chronic prostatitis 14 trials
- Trichomonas prostatitis 0 trials
- Gonococcal prostatitis 0 trials Sub-types →
- Granulomatous prostatitis 0 trials
- Prostatocystitis 0 trials
-
Pelvic inflammatory disease 4 trials · 14 incl. sub-types
4 sub-types
- Salpingitis 2 trials · 10 incl. sub-types Sub-types →
- Fitz-Hugh-Curtis syndrome 0 trials
- Acute female pelvic peritonitis 0 trials
- Parametritis 0 trials
-
Mastitis 11 trials
1 sub-type
- Neonatal infective mastitis 0 trials
-
Chorioamnionitis 10 trials
-
Perianal Crohn disease 10 trials
-
Labyrinthitis 0 trials · 9 incl. sub-types
6 sub-types
- Toxic labyrinthitis 9 trials
- Focal labyrinthitis 0 trials
- Infectious otitis interna 0 trials
- Purulent labyrinthitis 0 trials
- Serous labyrinthitis 0 trials
- Viral labyrinthitis 0 trials
-
Laryngitis 2 trials · 8 incl. sub-types
4 sub-types
- Acute laryngitis 1 trial · 6 incl. sub-types Sub-types →
- Laryngotracheitis 1 trial · 5 incl. sub-types Sub-types →
- Chronic laryngitis 0 trials
- Laryngeal tuberculosis 0 trials
-
Mediastinitis 6 trials
-
Urethritis 5 trials · 6 incl. sub-types
2 sub-types
- Ureaplasma urethritis 1 trial
- Gonococcal urethritis 0 trials
-
Panniculitis 3 trials · 6 incl. sub-types
6 sub-types
- Lipodermatosclerosis 1 trial
- Nodular non-suppurative panniculitis 1 trial
- Panniculitis and localized lipodystrophy 1 trial
- Cytophagic histiocytic panniculitis 0 trials
- Erythema nodosum 0 trials
- Lupus erythematosus panniculitis 0 trials
-
Thromboangiitis obliterans 4 trials
-
Enthesitis 2 trials
-
Epididymitis 2 trials
2 sub-types
- Epididymo-orchitis 0 trials Sub-types →
- Tuberculous epididymitis 0 trials
-
Omphalitis 2 trials
1 sub-type
- Funisitis 0 trials
-
Dacryocystitis 1 trial · 2 incl. sub-types
4 sub-types
- Chronic dacryocystitis 2 trials
- Acute dacryocystitis 0 trials
- Neonatal dacryocystitis 0 trials
- Phlegmonous dacryocystitis 0 trials
-
Orchitis 1 trial · 2 incl. sub-types
3 sub-types
- Vesiculitis 1 trial Sub-types →
- Epididymo-orchitis 0 trials Sub-types →
- Non-specific granulomatous orchitis 0 trials
-
Chronic inflammation of lacrimal passage 0 trials · 2 incl. sub-types
3 sub-types
- Chronic dacryocystitis 2 trials
- Chronic canaliculitis 0 trials
- Dacryocystocele 0 trials
-
Mastoiditis 1 trial
-
Radiculitis 1 trial
-
Balanitis 0 trials · 1 incl. sub-types
3 sub-types
- Balanitis xerotica obliterans 1 trial
- Anaerobic balanitis 0 trials
- Balanoposthitis 0 trials Sub-types →
-
Glossitis 0 trials · 1 incl. sub-types
2 sub-types
- Atrophic glossitis 0 trials · 1 incl. sub-types Sub-types →
- Median rhomboid glossitis 0 trials
-
Oophoritis 0 trials · 1 incl. sub-types
3 sub-types
- Salpingo-oophoritis 1 trial Sub-types →
- Autoimmune oophoritis 0 trials
- Tuberculous oophoritis 0 trials
-
IgG4-related pachymeningitis 0 trials
-
Amnionitis 0 trials
-
Cheilitis 0 trials
3 sub-types
- Melkersson-Rosenthal syndrome 0 trials
- Actinic cheilitis 0 trials
- Angular cheilitis 0 trials
-
Chronic pneumonitis of infancy 0 trials
-
Dacryoadenitis 0 trials
3 sub-types
- Acute dacryoadenitis 0 trials
- Chronic dacryoadenitis 0 trials
- Chronic lacrimal gland enlargement 0 trials
-
Diaphragmitis 0 trials
-
Endocervicitis 0 trials
-
Geniculate ganglionitis 0 trials
-
Gonococcal cervicitis 0 trials
2 sub-types
- Acute gonococcal cervicitis 0 trials
- Chronic gonorrhea of cervix 0 trials
-
Oral tuberculosis 0 trials
-
Parotitis 0 trials
-
Perinephritis 0 trials
-
Petrositis 0 trials
-
Placental villitis 0 trials
-
Posthitis 0 trials
1 sub-type
- Balanoposthitis 0 trials Sub-types →
-
Pyometritis 0 trials
1 sub-type
- Endomyometritis 0 trials
-
Ureteritis 0 trials
-
Uvulitis 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1718 trials in this tab.
-
Could a Half-Matched donor cure a rare immune disease?
Cure OngoingThis early-phase trial tests whether a bone marrow transplant from a partially matched relative can safely cure chronic granulomatous disease (CGD), a condition that causes severe infections and inflammation. Four people aged 4 to 65 with CGD and no perfect donor will receive che…
Early phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
New west nile vaccine enters first human tests
Vaccine OngoingThis early-stage trial is testing a new vaccine called HydroVax-001B WNV to see if it is safe and triggers an immune response against West Nile virus, a mosquito-borne disease. About 30 healthy adults aged 18 to 49 will receive either the vaccine or a placebo. The study will comp…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New vaccine strategy could shield lymphoma survivors from pneumonia
Vaccine OngoingThis study looks at how well a pneumonia vaccine (PCV20) works in people who have recovered from B-cell lymphoma and were treated with anti-CD20 therapy. Researchers want to see if a single dose or a boosted dose is safer and more effective at preventing pneumococcal infections. …
Phase 4 • Sponsor: M.D. Anderson Cancer Center • Aim: Vaccine
Last updated Sep 17, 2026 00:00 UTC
-
Booster shot for Moms-to-Be could shield newborns from deadly infections
Vaccine OngoingThis study follows women who previously received the GBS-NN/NN2 vaccine during pregnancy to see how long their immune protection lasts. It also tests whether a booster dose given in a new pregnancy is safe and boosts immunity, aiming to protect newborns from group B strep infecti…
Phase 2/3 • Sponsor: Minervax ApS • Aim: Vaccine
Last updated Sep 06, 2026 00:00 UTC
-
One shot, six protections: could a single vaccine replace multiple infant shots?
Vaccine OngoingThis trial tests a new vaccine called LBVD, which combines protection against six diseases: diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib. The study enrolls healthy infants around 6 to 8 weeks old who receive three doses at 6, 10, and 14 weeks of age. Researche…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Booster shot hope: extra hepatitis a vaccine studied for thai kids
Vaccine OngoingThis study looks at whether a second, inactivated hepatitis A vaccine can safely boost protection in healthy Thai children and teens who did not develop enough antibodies after a single dose of a live-attenuated hepatitis A vaccine. About 36 participants who took part in an earli…
Phase 3 • Sponsor: Chiang Mai University • Aim: Vaccine
Last updated Jun 27, 2026 12:37 UTC
-
New vaccine aims to train immune system against hepatitis b
Vaccine OngoingThis early-stage trial tests a new vaccine called AVX70371, designed to treat chronic hepatitis B by training the immune system to fight the virus. It involves 16 healthy adults aged 18 to 40 to check for safety and immune responses. The study is not yet testing if it works again…
Phase 1 • Sponsor: AstriVax Therapeutics • Aim: Vaccine
Last updated Jun 27, 2026 12:10 UTC
-
New hope for post-transplant bladder bleeding: cidofovir shows promise
Disease control OngoingThis study looked at whether adding the drug cidofovir to usual care helps people who develop painful bladder bleeding from the BK virus after a stem cell transplant. About 27 participants received either cidofovir or standard supportive care. The goal was to see if symptoms impr…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug riliprubart tested for Long-Term control of nerve disease CIDP
Disease control By invitation onlyThis study is a long-term extension of earlier trials testing the drug riliprubart in adults with CIDP, a condition where the immune system attacks the nerves, causing weakness and numbness. About 300 participants who completed a prior riliprubart study will continue receiving th…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for NASH: drug targets liver scarring in advanced disease
Disease control OngoingThis study tests an experimental drug, GSK4532990, in 284 adults with nonalcoholic steatohepatitis (NASH) and advanced liver scarring. The goal is to see if the drug can improve liver fibrosis and inflammation compared to a placebo over 52 weeks. Participants must have a liver bi…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to slow kidney failure in rare genetic disease
Disease control OngoingThis study tests an experimental drug called BAY 3401016 in 60 adults aged 18 to 45 with Alport syndrome, a rare genetic condition that damages kidneys, hearing, and eyes. The drug works by blocking a protein thought to cause kidney injury, with the goal of slowing the loss of ki…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New psoriasis drug shows promise for kids in Head-to-Head trial
Disease control OngoingThis study tests a new medicine called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab works better at clearing skin symptoms. About 168 participants will receive inj…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Gene therapy shot aims to tame autoimmune diseases in early trial
Disease control OngoingThis early-phase study tests a single injection of a gene therapy called V001-BCMA for people with autoimmune diseases like lupus that have not responded to standard treatments. The therapy targets and modifies specific immune cells to reduce disease activity. The main goal is to…
Early phase 1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two biologics go head to head in ulcerative colitis
Disease control OngoingResearchers compare two biologic drugs, ustekinumab and infliximab, in adults with moderate to severe ulcerative colitis who have not previously tried biologic therapy. The trial measures how well each drug reduces inflammation, controls symptoms, and improves quality of life, wh…
Sponsor: Helwan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can pulling a loose tooth and putting it back save it?
Disease control OngoingResearchers test whether intentionally removing, treating, and replanting a severely loose lower front tooth works better than splinting alone. Fifty adults with advanced periodontitis and at least 50% bone loss around the tooth join the study. Half receive replantation plus spli…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hip replacement bleeding breakthrough: drug could cut transfusions
Disease control OngoingThis study tests whether tranexamic acid, a drug that helps blood clot, can reduce blood loss during planned hip replacement surgery. About 1000 adults having elective hip replacement will receive the drug directly into the joint during surgery. The goal is to see if it lowers th…
Sponsor: St. Anne's University Hospital Brno, Czech Republic • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hip implant aims to fix cartilage without replacement
Disease control OngoingThis early study is testing a new device called the ReNew Hip Implant in 15 people aged 14 to 64 with hip cartilage damage from conditions like osteoarthritis or hip impingement. The implant is surgically placed to repair the cartilage. Researchers are checking if it is safe and …
Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Rotary bur vs piezo knife: which heals tooth bone better?
Disease control OngoingThis study compares two ways to remove infection at the tip of a tooth root: using a rotary bur (a small drill) or a piezoelectric unit (a vibrating tool). 124 adults with root infections will have surgery and then be followed for 12 months to see which method leads to better bon…
Sponsor: National and Kapodistrian University of Athens • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New stem cell approach aims to cure rare immune disease
Disease control OngoingThis study tests a high-dose stem cell transplant for people with chronic granulomatous disease (CGD), a condition that weakens the immune system. Participants receive donor stem cells along with drugs to prevent rejection and graft-versus-host disease. The goal is to improve tra…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a natural compound in food help beat knee implant infections?
Disease control PausedThis trial tests whether a dietary supplement called protocatechuic acid (PCA) can improve health markers in people undergoing revision surgery for a knee prosthetic joint infection. Participants take PCA before and after surgery, and researchers measure changes in immune and met…
Sponsor: Dr. Dean Reeves Clinic • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
Disease control OngoingSteroid injections for knee arthritis can temporarily raise blood sugar in people with type 2 diabetes. This trial tests whether giving a short course of NPH insulin right after the injection can prevent those high blood sugar episodes. Adults with type 2 diabetes and knee osteoa…
Phase 1/2 • Sponsor: Shifa International Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New oral drug balinatunfib tested for long-term control of Crohn's and colitis
Disease control OngoingThis study looks at the long-term safety and effectiveness of balinatunfib, an oral tablet, in adults with Crohn's disease or ulcerative colitis. Participants have already completed a one-year treatment in a previous study. The trial will last up to 107 weeks and includes both do…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a skin cream bring back color to faces with vitiligo?
Disease control OngoingResearchers are testing a cream called delgocitinib on facial vitiligo, a condition where skin loses its color in patches. Twelve adults with non-segmental vitiligo on the face will apply the cream twice daily for 24 weeks. The trial measures changes in the size and severity of w…
Phase 2 • Sponsor: Lone Skov • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a special toothpaste keep your gums healthy?
Disease control OngoingThis study looks at whether a toothpaste with a special gum-health ingredient can improve gum health in people with gingivitis. 150 adults will use the test toothpaste for 13 weeks, then switch to a regular fluoride toothpaste for 4 weeks. Researchers will measure gum inflammatio…
Sponsor: Unilever R&D • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New acne gel put to the test for Year-Long safety
Disease control OngoingThis study is testing whether a new gel applied daily for up to 52 weeks is safe for people with acne. About 400 participants will use the gel on their face and upper body and visit the clinic regularly for checkups. The main goal is to track any side effects, not to measure how …
Phase 3 • Sponsor: PPM Services S.A. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug shows promise for painful skin condition
Disease control OngoingThis study tests a new drug called tulisokibart in 147 people with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. Participants are randomly assigned to receive either the drug or a placebo, and researchers will check if the drug reduc…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a vaccine tame chronic hepatitis b?
Disease control OngoingThis early-stage trial tests a therapeutic vaccine called ISA104 in 24 people with chronic hepatitis B who are already on antiviral drugs. The goal is to see if the vaccine is safe and can boost the immune system to better fight the virus. Participants will receive either ISA104 …
Phase 1/2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Scientists probe whether lebrikizumab rewires diseased skin at the molecular level
Disease control OngoingResearchers are studying lebrikizumab, an approved injectable drug for atopic dermatitis, to understand how it changes skin biology over time. The trial enrolls 48 people with moderate-to-severe atopic dermatitis who have not done well on topical treatments. Participants receive …
Phase 4 • Sponsor: Johann E Gudjonsson MD PhD • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody cocktail aims to tame ulcerative colitis for good
Disease control By invitation onlyThis study is testing three long-acting antibodies, alone or in combination, in 645 people with ulcerative colitis. The goal is to see if they are safe and can improve bowel inflammation over 48 weeks. Participants are joining from a previous study and may have already seen some …
Phase 2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New gene therapy aims to fix immune system in rare disease
Disease control By invitation onlyThis study tests a new gene therapy for people with chronic granulomatous disease (CGD), a genetic disorder that weakens the immune system and makes them prone to serious infections. The treatment takes the patient's own blood stem cells, adds a missing gene in the lab, and puts …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for ulcerative colitis: phase 3 trial of afimkibart underway
Disease control OngoingThis Phase 3 trial tests whether the drug Afimkibart can help people with moderate-to-severe ulcerative colitis achieve remission. About 400 adults who have not responded well to other treatments will receive either Afimkibart or a placebo. The study measures remission at 12 and …
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a daily ultrasound zap arthritis pain at home?
Disease control OngoingThis study tests a non-invasive device that uses ultrasound to stimulate the spleen and reduce inflammation in people with moderate to severe rheumatoid arthritis. About 60 adults who haven't responded well to standard medications will use the device at home for 12 weeks, with so…
Sponsor: SecondWave Systems Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Patient's own blood beat a standard dressing for dry socket?
Disease control OngoingThis trial tests two treatments for dry socket, a painful complication after tooth extraction. One is Alvogyl, a standard medicated dressing. The other is platelet-rich fibrin (PRF), made from the patient's own blood, which may help tissue heal. About 102 adults with dry socket w…
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
DNA vaccine trial aims to train immune system against hepatitis c
Disease control OngoingThis early-stage trial tests a DNA vaccine called INO-8000, given with an immune booster, to see if it can help people with chronic hepatitis C fight the virus. The study involves 33 participants and focuses on safety and finding the best dose. The vaccine is delivered through in…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug zanubrutinib takes on kidney disease in major trial
Disease control OngoingThis study tests whether the drug zanubrutinib can help people with primary membranous nephropathy, a kidney disease that causes protein leakage. About 178 participants will receive either zanubrutinib or the standard drug tacrolimus. The goal is to see if zanubrutinib reduces pr…
Phase 2/3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill could tame severe ulcerative colitis Flare-Ups
Disease control OngoingThis study tests an experimental drug called SAR441566 in about 204 adults with moderate-to-severe ulcerative colitis, a chronic bowel disease causing inflammation and symptoms like diarrhea and bleeding. Participants will receive either the drug or a placebo for up to 52 weeks t…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can an oral drug calm psoriatic arthritis? phase 3 trial puts deucravacitinib to the test
Disease control OngoingResearchers are testing whether deucravacitinib, a daily oral drug, can reduce joint swelling, tenderness, and skin symptoms in people with active psoriatic arthritis. The trial enrolls adults who have not taken biologic drugs for their arthritis or who previously received a TNF …
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hepatitis b drug shows promise in Mid-Stage trial
Disease control OngoingThis Phase 2 study tests an experimental drug called ALG-000184 against a standard hepatitis B medication (tenofovir) in 200 adults with chronic hepatitis B. Participants take one pill daily for 48 weeks. The main goal is to see if the new drug can lower hepatitis B virus levels …
Phase 2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New pill could tame ulcerative colitis Flare-Ups
Disease control OngoingThis study tests an experimental oral drug called GS-5290 (tilpisertib fosmecarbil) in 176 adults with moderate to severe ulcerative colitis. Participants are randomly assigned to receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug can improve s…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug combo aims to tame chronic hepatitis b
Disease control OngoingThis Phase 2 trial tests whether adding TQ-A3334 tablets to standard nucleoside analog drugs can better control chronic hepatitis B. About 116 adults with the infection will receive either the combination or a placebo plus standard drugs. The main goal is to see if the combinatio…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for teens with severe skin disease: drug trial launches
Disease control OngoingThis study tests a drug called bimekizumab in teenagers (ages 9 to 17) with moderate to severe hidradenitis suppurativa, a painful skin condition that causes boils. The goal is to see how the drug moves through the body and if it is safe. About 40 participants will receive the dr…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could CAR t cells tame vasculitis? early trial aims to find out
Disease control OngoingThis early-phase trial is testing a new treatment called CC-97540, a type of CAR T cell therapy, in 12 people with severe ANCA-associated vasculitis that has not responded to standard treatments. The therapy is designed to target and destroy certain immune cells that drive the di…
Phase 1/2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New antibiotic vabomere tested in kids with tough UTIs
Disease control OngoingThis study tests the safety of an antibiotic called Vabomere in children aged 3 months to 12 years who have complicated urinary tract infections, including kidney infections. The children receive the medicine through an IV while in the hospital. Researchers monitor for side effec…
Phase 2 • Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a toothpaste ingredient reshape the microbes behind gum disease?
Disease control By invitation onlyThis trial tests whether a toothpaste containing arginine can alter the bacteria living below the gumline in people with gum disease who are already receiving ongoing dental care. Participants will brush twice daily for six months with either an arginine toothpaste or a standard …
Sponsor: Sukirth M Ganesan, BDS, PhD • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can tailoring bypass length improve weight loss surgery results?
Disease control By invitation onlyResearchers are studying how the length of bypassed intestine during gastric bypass affects weight loss, complications, and metabolic changes in people with severe obesity. Participants will have different lengths of intestine bypassed and will provide blood and stool samples bef…
Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for kidney transplant patients: extended drug trial targets rejection
Disease control By invitation onlyThis study offers kidney transplant patients with antibody-mediated rejection (AMR) the chance to receive felzartamab for up to 4 more years. AMR occurs when the immune system attacks the new kidney. The main goal is to check long-term safety and monitor kidney health through bio…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Cord blood stem cells aim to tame COVID-19 lung crisis
Disease control OngoingThis study tests whether infusions of cord blood stem cells can help people with moderate to critical COVID-19 pneumonia. The trial includes 65 adults with COVID-19-related acute respiratory distress syndrome (ARDS). Researchers will compare stem cell treatment plus standard care…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New dialysis filter aims to cut inflammation and protect hearts in kidney patients
Disease control OngoingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can reduce inflammation and improve heart function better than the standard filter in people with end-stage kidney disease. Thirty adults on maintenance hemodialysis will use each filter for three …
Sponsor: Gazi University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New arthritis drug shows promise in Long-Term safety trial
Disease control By invitation onlyThis study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with psoriatic arthritis. About 1560 adults who finished an earlier study will receive the drug as a shot under the skin. Researchers will track side effects and how well the drug c…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Stem cells may boost islet transplants for pancreatitis patients
Disease control OngoingThis study tests whether adding a person's own bone marrow stem cells to their islet transplant can help the islets survive longer and work better. It includes 42 adults with chronic pancreatitis who are already scheduled for pancreas removal and islet auto-transplant. Participan…
Phase 1 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gene fix trial aims to tame rare immune disease
Disease control By invitation onlyThis study tests a gene therapy for people with X-linked chronic granulomatous disease (X-CGD), a genetic condition that weakens the immune system and leads to severe infections. Researchers take the patient's own stem cells, add a working copy of the faulty gene, and return the …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo aims to tame deadly fat levels in the blood
Disease control OngoingThis Phase 2 trial tests two experimental injections, HRS-7249 and SHR-1918, in 108 adults with severely high triglycerides who are at high risk of acute pancreatitis. The study aims to see if these drugs can safely lower fat levels in the blood and reduce the chance of a pancrea…
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New eczema drug combo enters early human testing
Disease control OngoingThis early-stage trial is testing a combination of two experimental drugs, APG777 and APG990, in 86 adults with moderate-to-severe atopic dermatitis (eczema). The main goal is to check safety and how the drugs move through the body, comparing them to the existing treatment Dupixe…
Phase 1 • Sponsor: Apogee Therapeutics, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New gene shot could regrow knee cartilage and ease arthritis pain
Disease control CancelledThis early-phase study tests a single injection of ICM-203, a gene therapy that delivers a gene to promote cartilage growth and reduce inflammation in the knee. About 18 adults with mild to moderate knee osteoarthritis will receive escalating doses to check safety and whether it …
Phase 1/2 • Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug hope for rare kidney disease: daratumumab trial launches
Disease control OngoingThis study tests a drug called daratumumab in 40 people with a rare kidney condition called PGNMID, where abnormal proteins damage the kidneys. Participants receive weekly injections for 8 weeks, then every two weeks for another 8 weeks. The goal is to see if the drug can reduce …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could allergy pills calm irritable bowel syndrome?
Disease control CancelledThis trial tests whether a combination of two common antihistamines, cetirizine and famotidine, can reduce symptoms in people with diarrhea-predominant irritable bowel syndrome (IBS-D). Participants take the antihistamines or a placebo for 30 days, then switch, so each person ser…
Phase 3 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to stop relapses in rare brain disease
Disease control OngoingThis phase 3 trial tests whether satralizumab can prevent relapses in people with MOGAD, a rare disease where the immune system attacks the brain and spinal cord. About 152 participants aged 12 and older will receive either the drug or a placebo. The main goal is to see if satral…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Diabetes drug semaglutide tested as potential treatment for fatty liver disease NASH
Disease control OngoingThis study tests whether semaglutide, a medicine already used for type 2 diabetes, can help people with NASH, a serious liver condition. About 1205 adults with NASH and liver scarring (stage 2 or 3) will receive weekly injections of semaglutide or a placebo for up to 5 years. The…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a single injection drug calm the immune attack on kidneys?
Disease control OngoingThis phase 2 trial tests an experimental drug called SGB-9768 in adults with three related kidney diseases: IgA nephropathy, C3 glomerulopathy, and immune complex-mediated membranoproliferative glomerulonephritis. These conditions occur when the immune system deposits proteins in…
Phase 2 • Sponsor: Suzhou Sanegene Bio Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection tame hereditary swelling attacks?
Disease control ApprovedThis program provides access to an investigational drug called donidalorsen for people with hereditary angioedema (HAE), a genetic condition that causes sudden, painful swelling in various body parts. The drug is given as a monthly or every-other-month injection under the skin. I…
Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a One-Time immune cell treatment tame severe vasculitis?
Disease control OngoingThis Phase 2 trial tests a one-time infusion of rapcabtagene autoleucel, a CAR-T cell therapy made from a patient's own immune cells, against standard treatments for severe active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). About 126 adults aged 18-7…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New pill aims to keep ulcerative colitis in check for a year
Disease control OngoingThis study looks at the safety and effectiveness of Velsipity tablets taken daily for up to 52 weeks by people with moderate to severe ulcerative colitis. About 553 participants will be followed in real-world medical settings. The goal is to see if the drug can help control sympt…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Immune cell reprogramming offers hope for stubborn arthritis and Sjogren's
Disease control OngoingThis early-phase study tests a personalized cell therapy (rapcabtagene autoleucel) in 27 adults with difficult-to-treat rheumatoid arthritis or severe Sjogren's disease. The treatment uses a patient's own immune cells, modified to target and calm the overactive immune system. The…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for lung fibrosis patients: inhaled drug tested for long-term safety
Disease control By invitation onlyThis study looks at the long-term safety of an inhaled medication called treprostinil for people with fibrotic lung diseases like idiopathic pulmonary fibrosis. About 1,850 adults who completed a prior related study will take the drug and be monitored for side effects. The goal i…
Phase 3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug GS-0151 tested for rheumatoid arthritis in early trial
Disease control OngoingThis early-stage trial is testing a new drug called GS-0151 in 75 adults with rheumatoid arthritis. The main goal is to see if the drug is safe and how the body processes it. Participants will receive either GS-0151 or a placebo for 12 weeks.
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
When waters break early, does acting fast beat waiting?
Disease control By invitation onlyThis trial studies women whose water breaks before labor starts, a condition called premature rupture of membranes, at 37 to 42 weeks of pregnancy. Half the participants will have labor induced within 24 hours using a vaginal gel, while the other half will wait up to 24 hours for…
Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug CND261 tested for rheumatoid arthritis relief
Disease control OngoingThis early-stage study tests a new drug, CND261, in 47 adults with moderate to severe rheumatoid arthritis who haven't responded well to other treatments. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that it might…
Phase 1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new knee implant design offer better Long-Term relief?
Disease control By invitation onlyThis study tests a new total knee replacement system called LinkSymphoKnee, which uses an ultra-congruent bearing surface designed to provide stability and mimic natural knee movement. Researchers will enroll 600 adults aged 18 to 79 who need a knee replacement due to osteoarthri…
Sponsor: LinkBio Corp. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy for knee pain: does it last?
Disease control OngoingThis study follows 16 people who previously received ICM-203 (a gene therapy) or a placebo for knee osteoarthritis. Researchers will track delayed side effects and measure changes in knee pain and function over time. The goal is to understand the long-term safety and effectivenes…
Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Tailored breathing support may reduce lung injury in ECMO patients
Disease control By invitation onlyThis study tests whether personalized ventilator settings can reduce lung injury in adults with severe respiratory failure who are on ECMO (a heart-lung machine). Researchers will use esophageal manometry or electrical impedance tomography to tailor the ventilator's positive pres…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a cancer drug stop the body from making extra bone?
Disease control OngoingThis phase 2 trial tests whether saracatinib, an oral drug originally developed for cancer, can prevent new abnormal bone growth in adults with fibrodysplasia ossificans progressiva (FOP), a rare genetic condition where muscle and soft tissue turn into bone. Twenty adults with ac…
Phase 2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can navigation make hip replacements more precise?
Disease control OngoingThis trial tests whether using a navigation system during hip replacement surgery leads to more accurate joint reconstruction than the traditional measured technique. Researchers will compare the surgeon's pre-operative 3-D plan with the actual post-operative result in 100 patien…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hip implant aims to cut repeat surgeries
Disease control OngoingThis study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to chec…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
One-Time cell therapy could tame tough lupus
Disease control OngoingThis study tests a one-time treatment called rapcabtagene autoleucel, made from a patient's own immune cells, for people with active lupus or lupus kidney disease that hasn't improved with standard therapies. About 179 adults will receive the treatment after a short chemotherapy …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug lutikizumab aims to ease painful skin lumps in major trial
Disease control OngoingThis phase 3 trial tests the drug lutikizumab against a placebo in about 1400 adults and teens with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps and abscesses. Participants receive weekly shots for 16 weeks, then continue on differen…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a poop pill save lives? new trial targets superbug lung infections in ICU patients
Disease control CancelledThis study tests whether fecal microbiota transplantation (FMT) — transferring healthy donor stool into the gut — can lower the risk of death in ventilated ICU patients with multidrug-resistant lung infections. The idea is that restoring gut bacteria may help fight lung infection…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single infusion stop GPP flares in their tracks?
Disease control OngoingThis study is testing whether the drug spesolimab can safely and effectively treat repeated flares of generalized pustular psoriasis (GPP), a serious skin condition. Adults with GPP who have had a flare will receive a single intravenous dose of spesolimab, with a possible second …
Phase 4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for chronic mouth condition: baricitinib trial launches
Disease control OngoingThis study tests whether baricitinib, a drug used for arthritis, can help people with moderate to severe oral lichen planus—a painful mouth condition. Ten adults who haven't improved with other treatments will take the drug for six months. Researchers will measure changes in mout…
Phase 2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill could ease painful skin lumps for those failed by antibiotics
Disease control OngoingThis study tests a daily pill called ritlecitinib for adults with moderate to severe hidradenitis suppurativa (HS), a condition causing painful red skin lumps. About 240 participants who haven't been helped by antibiotics will be randomly assigned to get the drug or a placebo for…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug shows promise for rare skin disease over nearly 5 years
Disease control OngoingThis study looks at the long-term safety and effectiveness of spesolimab in people with generalized pustular psoriasis (GPP), a rare and severe skin condition. All 131 participants had already taken spesolimab in a previous study and will continue treatment for up to 5 years. Res…
Phase 2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New shot aims to restore skin color in vitiligo patients
Disease control OngoingThis early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo. The main goal is to see if the drug is safe when given as a shot under the skin. Researchers will also look for early signs that it might help bring back skin color. The study lasts 84 weeks, inc…
Phase 1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThis phase 3 study tests an experimental oral drug, JNJ-77242113, in about 731 adults with moderate to severe plaque psoriasis. Participants receive either the new drug, a placebo, or an active comparator (deucravacitinib) to see how well it clears skin lesions. The main goal is …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug guselkumab shows promise for ulcerative colitis in large trial
Disease control OngoingThis study tests guselkumab, a drug that targets inflammation, in over 1,000 people with moderate to severe ulcerative colitis. Participants receive either guselkumab or a placebo to see if the drug can improve symptoms and lead to remission. The goal is to find a new treatment o…
Phase 2/3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill shows promise for rare, severe psoriasis
Disease control OngoingThis phase 3 trial tests an oral drug called JNJ-77242113 in 19 people with two rare and severe forms of psoriasis: generalized pustular psoriasis and erythrodermic psoriasis. The study measures how many participants see improvement after 16 weeks of treatment. It is an open-labe…
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for rare liver disease: drug trial targets bile duct damage
Disease control OngoingThis study tests a drug called elafibranor in 68 adults with primary sclerosing cholangitis (PSC), a rare liver disease that damages bile ducts. The main goal is to check the drug's safety and side effects compared to a placebo. Researchers will also look at blood tests to see if…
Phase 2 • Sponsor: Ipsen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kids with stubborn psoriasis: drug trial shows promise
Disease control OngoingThis study tests a drug called guselkumab in children aged 6 to 17 with chronic plaque psoriasis. The goal is to see if it safely clears skin patches better than a placebo or another treatment. About 120 participants will receive injections and be monitored for 16 weeks.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for kids with severe colitis: drug trial shows promise
Disease control OngoingThis study tests a drug called golimumab in children aged 2-17 with moderate-to-severe ulcerative colitis, a chronic bowel disease causing inflammation and symptoms like diarrhea and bleeding. The goal is to see if the drug can bring about remission (symptom relief) within 6 week…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New nanozyme treatment could revolutionize root canal disinfection
Disease control By invitation onlyThis study compares a new cleaning solution made from ferumoxytol nanozymes to the standard treatment for root canal infections. About 72 adults with infected teeth will receive either the new solution or the usual one during their root canal procedure. Researchers will measure h…
Phase 4 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New biologic mirikizumab put to the test against standard therapies for IBD
Disease control By invitation onlyThis study compares the real-world effectiveness of mirikizumab against standard biologic therapies for adults with ulcerative colitis or Crohn's disease. Researchers will track whether mirikizumab reduces the need for extra medical care, like emergency visits or treatment change…
Phase 4 • Sponsor: Specialty Networks Research. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A cup of beans a day: could it calm inflammation and boost insulin response?
Disease control OngoingThis trial tests whether eating a cup of black beans or chickpeas every day for 12 weeks can reduce inflammation and improve insulin sensitivity in adults who are overweight or have elevated blood sugar. Participants are randomly assigned to eat beans, chickpeas, or rice as a con…
Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a diet calm inflamed joints in children with arthritis?
Disease control OngoingResearchers are testing whether a specific carbohydrate diet, which has anti-inflammatory effects in children with inflammatory bowel disease, can also reduce joint inflammation in children with juvenile idiopathic arthritis. The trial includes children up to age 16 with low to m…
Sponsor: Uppsala University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a disc made from donated tissue ease severe dry eye?
Disease control CancelledThis Phase 3 trial tests whether a disc made from donated human amnion membrane can help people with moderate to severe dry eye disease. The disc is placed on the eye and compared to standard care like lubricating drops and a bandage lens. The study will enroll 40 adults who have…
Phase 4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a pill keep vitiligo at bay? new study aims to find out
Disease control OngoingThis study tests a daily pill called ritlecitinib in adults and teens with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the medicine can maintain or improve skin color regained in a previous study, or if stopping it leads to colo…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a single bone screw save ankles from arthritis?
Disease control OngoingThis trial compares two surgical approaches for a common type of ankle fracture. Half of the participants will have the posterior bone fragment fixed with a plate or screw, while the other half will not. The goal is to see if fixing this fragment makes the ankle joint stable enou…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a blood pressure pill shield blood vessels from heart attacks?
Disease control OngoingThis trial tests whether sparsentan, a tablet that blocks a chemical called endothelin and lowers blood pressure, can improve blood vessel function and reduce stiffness in people with ANCA-associated vasculitis. Vasculitis is an autoimmune disease that damages blood vessels and r…
Phase 2 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Seaweed extract may soothe inflamed guts — trial puts it to the test
Disease control By invitation onlyThis trial asks whether a supplement made from brown algae, called fucoidan, can improve gut health in people with mild to moderate ulcerative colitis. Participants will take fucoidan or a placebo alongside their usual medication for 12 weeks. Researchers will measure changes in …
Phase 1/2 • Sponsor: Allama Iqbal Medical College • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New ankle implant tracked for 10 years in arthritis patients
Disease control OngoingThis study follows 200 adults with ankle arthritis who received the INFINITY ankle replacement. Researchers will check how long the implant lasts and monitor for any problems like loosening or cysts over 10 years. The goal is to see if this device works as well as other similar i…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can telemedicine bring IV antibiotics home?
Disease control OngoingThis trial tests a new model where patients with infections receive intravenous antibiotics at home instead of staying in the hospital. Nurses from a municipal response team visit the patient, while hospital doctors oversee the treatment remotely using telemedicine and welfare te…
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New study checks if etrasimod tames ulcerative colitis symptoms in daily life
Disease control OngoingThis study looks at how well etrasimod works for people with moderate to severe ulcerative colitis when used in normal doctor visits. About 360 adults aged 18 to 65 will take etrasimod as prescribed by their doctor and fill out health questionnaires online. Researchers will track…
Sponsor: Pfizer • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Surgery or strength? new study pits hip replacement against exercise for arthritis pain
Disease control OngoingThis study compares two treatments for end-stage hip osteoarthritis: total hip replacement surgery and progressive resistance training (strength exercises). About 109 adults aged 50 and older with severe hip arthritis will be randomly assigned to one of the two treatments. The ma…
Sponsor: Vejle Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a personalized diet tame rheumatoid arthritis and protect the heart?
Disease control By invitation onlyThis study tests whether a personalized diet, based on the latest Nordic Nutrition Recommendations, can reduce disease activity and cardiovascular risk in people newly diagnosed with rheumatoid arthritis. About 150 participants will be randomly assigned to either a diet following…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Gut bacteria may predict who benefits from prebiotics in ulcerative colitis
Disease control CancelledThis trial tests whether a prebiotic supplement can ease symptoms in people with mild ulcerative colitis, a chronic inflammatory bowel disease. Participants will take either the prebiotic or a placebo for eight weeks. The study aims to see if certain gut bacteria patterns can pre…
Sponsor: Wageningen University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a donor heart valve beat Man-Made ones for treating severe valve infections?
Disease control OngoingThis study compares two approaches for replacing an infected aortic valve: using a cryopreserved aortic homograft (a preserved human donor valve) versus conventional mechanical or tissue prosthetic valves. The goal is to see which method leads to fewer complications, such as deat…
Sponsor: Centre Cardiologique du Nord • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Which knee implant stays put longer? a Head-to-Head test
Disease control OngoingThis trial aims to see if there is a difference in how well two cementless total knee replacement implants hold up over time. About 50 people with knee osteoarthritis will be randomly assigned to receive either the Triathlon Tritanium or the GMK Sphere implant. Using CT scans, re…
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could an extra dose of antibiotics during appendix surgery cut infection risk?
Disease control OngoingThis study looks at whether giving an extra dose of the antibiotic cefoxitin during appendix removal surgery can better prevent infections compared to the usual single dose before surgery. Researchers will measure antibiotic levels in blood, fat, and appendix tissue from 46 parti…
Phase 1 • Sponsor: University of Michigan • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Ceramic hip resurfacing: a Metal-Free future for joint replacement?
Disease control OngoingThis study is testing a new type of hip resurfacing device made entirely of ceramic, designed for people with hip osteoarthritis, necrosis, or dysplasia. The goal is to see if it is as safe and effective as existing metal-on-metal devices, but without releasing metal ions into th…
Sponsor: Embody Orthopaedic Limited • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a single Immune-Targeting drug quiet an autoimmune kidney disease?
Disease control OngoingThis trial tests whether rituximab, an infusion drug that calms certain immune cells, can help people with idiopathic membranous nephropathy and nephrotic syndrome. Participants receive either rituximab or a placebo, and the study tracks how many achieve a significant reduction i…
Phase 3 • Sponsor: Shoichi Maruyama MD PhD • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a phone app beat fatty liver? new trial tests digital coaching
Disease control OngoingThis trial tests whether a smartphone app and remote diet/exercise coaching can help people with non-alcoholic fatty liver disease lose weight and reduce liver fat. 120 participants will either get standard lifestyle advice or use the app with daily meal tracking, weekly recipe a…
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a simple dental procedure save teeth from root canals?
Disease control OngoingThis trial compares two dental procedures—direct pulp capping and partial pulpotomy—for treating permanent teeth with deep cavities that expose the pulp. Adults with deep caries and reversible pulpitis will be randomly assigned to one of the two procedures. The study will follow …
Sponsor: King Abdullah University Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Which knee implant feels more natural? a trial puts two designs to the test
Disease control OngoingThis trial compares two types of knee replacement implants: one that keeps the posterior cruciate ligament (CR) and one that does not (PS). Both are implanted using a computer-assisted personalized technique that aims to restore the knee's natural alignment. The study includes 14…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
A simple marker might predict which teeth can be saved without root canal
Disease control OngoingThis study tests whether the level of a specific inflammatory marker (MMP9) in the dental pulp can predict the success of a full pulpotomy, a procedure that removes the inflamed pulp from the crown of a tooth and seals it with a special material. Adults with deep cavities causing…
Sponsor: King Abdullah University Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Ear cartilage to the rescue? a tiny biopsy could rebuild knees
Disease control OngoingThis trial is testing whether a single injection of micrografts made from a patient's own ear cartilage can improve symptoms and knee function in adults with moderate knee osteoarthritis. The micrografts are prepared from a small ear cartilage sample using a special device, witho…
Sponsor: Regenera Activa Worldwide S.L. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a gut metabolite shield the kidneys in IgA nephropathy?
Disease control By invitation onlyThis trial tests whether sodium butyrate, a short-chain fatty acid, can reduce protein in the urine and slow kidney function decline in people with IgA nephropathy, a kidney disease. Participants receive either sodium butyrate or a placebo for 12 weeks, then switch after a washou…
Early phase 1 • Sponsor: University Hospital, Martin • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Decades-Old drug reverse pancreatic scarring?
Disease control OngoingThis trial tests whether proglumide, an older drug that blocks a specific receptor, can safely reduce pain and slow or reverse the scarring seen in chronic pancreatitis. The study includes adults with confirmed chronic pancreatitis and compares proglumide against a placebo over 1…
Phase 1/2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could exercise replace the scalpel for shoulder arthritis?
Disease control By invitation onlyThis trial tests whether a 12-week program of physical therapy or home exercises can reduce pain and improve shoulder function in adults with glenohumeral arthritis, compared with no treatment. Participants are randomly assigned to one of three groups: supervised physical therapy…
Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a new pill ease arthritis in kids?
Disease control OngoingThis study is testing an oral medication called upadacitinib in children with polyarticular juvenile idiopathic arthritis (JIA), a condition causing joint inflammation. The goal is to understand how the drug moves through the body, its safety, and how well children tolerate it. P…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can inhaled nitric oxide speed pneumonia recovery?
Disease control OngoingThis trial investigates whether adding high-dose inhaled nitric oxide to standard antibiotics can help people with pneumonia recover faster. The study includes 200 adults with hospital-acquired or community-acquired pneumonia. Participants receive either nitric oxide or a sham tr…
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New antibody aims to calm eczema Flare-Ups from the inside
Disease control OngoingThis study tests an experimental drug called BFB759, a lab-made antibody that blocks several inflammatory signals at once. Researchers want to see if it can reduce redness, swelling, and itching in adults with moderate-to-severe eczema that hasn't improved with creams. About 225 …
Phase 2 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a donor corneal disc heal scarred eyes from herpes?
Disease control By invitation onlyThis trial tests whether implanting a thin disc of donor cornea tissue — called a stromal lenticule — can improve corneal transparency and vision in people with herpetic stromal keratitis, a herpes infection that scars the cornea. The lenticule contains stem cells and other livin…
Sponsor: Eye Hospital Pristina Kosovo • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Antibiotics or watchful waiting? a trial puts ventilator tracheobronchitis to the test
Disease control OngoingThis trial tests whether giving antibiotics for a week is better than simply monitoring patients who develop ventilator-associated tracheobronchitis, a lung airway infection common in ICU patients on breathing machines. Researchers will compare how many days patients are free fro…
Sponsor: Hospital Sirio-Libanes • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a JAK-Inhibitor cream recolor white patches caused by cancer treatment?
Disease control OngoingThis study tests whether a topical cream containing ruxolitinib can safely restore skin color in people who develop white patches (vitiligo-like depigmentation) as a side effect of cancer immunotherapy. The cream is applied twice daily for 52 weeks. Researchers will measure how m…
Phase 2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a standard 28-Day antibiotic course beat flexible dosing for abdominal infections?
Disease control OngoingThis trial compares a fixed 28-day antibiotic course against standard care (where the duration is decided by the doctor) in adults hospitalized with complicated intra-abdominal infections. About 1,100 participants will be randomly assigned to one of the two approaches and followe…
Phase 3 • Sponsor: Lydia Flett • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a new drug tame vasculitis with fewer side effects?
Disease control OngoingThis study tracks the safety of avacopan, a medication for ANCA-associated vasculitis, an autoimmune disease that causes blood vessel inflammation. Researchers will compare side effects like liver injury, heart problems, serious infections, and cancer in people taking avacopan ve…
Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a tailored antibiotic regimen shorten endocarditis treatment without risk?
Disease control OngoingThis trial investigates whether a shorter course of antibiotics, tailored to each patient's response, can treat left-sided endocarditis as safely as the standard 4-6 week regimen. Adults with endocarditis caused by specific bacteria (Streptococci, Enterococcus faecalis, or Staphy…
Sponsor: Herlev Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a tailored antibiotic regimen shorten endocarditis treatment without risk?
Disease control OngoingThis trial investigates whether a shorter course of antibiotics, tailored to each patient's response, can safely treat bacterial endocarditis. Standard treatment lasts 4-6 weeks, but this study tests a personalized approach based on factors like fever and blood tests. The goal is…
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Cow's first milk could be a lifeline for severe Alcohol-Related hepatitis
Disease control OngoingThis phase 3 trial investigates whether bovine colostrum—the nutrient-rich first milk from cows—can improve survival in people with severe alcohol-associated hepatitis. The condition involves liver inflammation, a leaky gut, and a high risk of infection. Participants receive eith…
Phase 3 • Sponsor: Dayanand Medical College and Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug D-2570 aims to quiet Flare-Ups in ulcerative colitis
Disease control OngoingThis study tests whether an experimental drug called D-2570 can help people with moderately to severely active ulcerative colitis achieve remission. About 120 adults will receive either D-2570 or a placebo daily for 12 weeks. The main goal is to see if more people on D-2570 reach…
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a triple therapy tackle diabetes, high blood pressure, and arthritis at once?
Disease control CancelledThis study investigates whether adding two common drugs—valsartan (for high blood pressure) and celecoxib (for arthritis pain)—to standard metformin therapy can improve blood sugar control in people with type 2 diabetes. The trial enrolls adults with obesity, high blood pressure,…
Phase 1/2 • Sponsor: ARKAY Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Which shoulder surgery works best for seniors with arthritis? a Head-to-Head trial
Disease control OngoingThis study compares two types of shoulder replacement surgery—Total Shoulder Arthroplasty (TSA) and Reverse Total Shoulder Arthroplasty (RTSA)—in people aged 65 and older with advanced shoulder osteoarthritis. Participants are randomly assigned to one of the two procedures. The g…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a 4-Minute chat rival a Dietitian's hour for heart health?
Disease control OngoingThis study tests whether a short, standardized 4-minute heart-healthy talk is as effective as a full 60-minute personalized session with a dietitian for lowering LDL cholesterol and improving diet. Participants are adults aged 30–80 with rheumatoid arthritis, psoriatic arthritis,…
Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can better hospital discharge planning keep seniors out of the ER?
Disease control OngoingThis study tests a transitional care model for older adults (65+) hospitalized with heart failure, COPD, or pneumonia. The model provides extra education, social services, and coordination among doctors after discharge. Researchers compare this to usual care to see if it reduces …
Sponsor: Mathematica Policy Research, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New tooth root sealer aims to boost healing and cut pain
Disease control PausedThis study tests a new heat-resistant calcium silicate-based sealer used during root canals in people with infected tooth roots (apical periodontitis). The sealer is applied with different filling techniques to see if it improves bone healing and reduces pain after treatment. Par…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Two-Drug combo aims to cure chronic hepatitis b
Disease control OngoingThis study tests whether giving two experimental drugs in sequence can achieve a functional cure for chronic hepatitis B. Participants are adults with chronic HBV who are already on standard antiviral therapy. They will receive either one of two doses of daplusiran/tomligisiran f…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug may reverse liver damage in NASH patients
Disease control OngoingThis study tests a drug called lanifibranor in 1000 adults with NASH (a fatty liver disease) and moderate liver scarring (stages F2 or F3). The goal is to see if the drug can reverse the scarring and reduce liver inflammation over 72 weeks. Participants are randomly assigned to r…
Phase 3 • Sponsor: Inventiva Pharma • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a diabetes drug shield kidneys from lupus damage?
Disease control OngoingThis phase 2 trial tests whether dapagliflozin, a drug already used for diabetes and chronic kidney disease, can slow kidney damage in people with lupus nephritis. Lupus nephritis is a serious complication of lupus that causes kidney inflammation and can lead to chronic kidney di…
Phase 1/2 • Sponsor: Hospital Civil Juan I. Menchaca • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could donated tissue help heal stubborn wounds? new study investigates
Disease control OngoingThis early-stage study is testing whether a specially prepared membrane made from donated human tissue can help heal chronic wounds, like diabetic foot ulcers and eye surface injuries. The membrane is sterilized with different doses of radiation to find the best balance between s…
Phase 1 • Sponsor: Libyan Center for Biotechnology Research • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a daily pill help restore skin color in vitiligo?
Disease control OngoingThis Phase 3 study tests ritlecitinib, an oral drug, in adults with nonsegmental vitiligo, a condition causing white patches on the skin. About 1,571 participants will receive either 50 mg, 100 mg of ritlecitinib, or a placebo daily for up to 104 weeks. The goal is to see if the …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Pregnant women with hepatitis b: which drug is safer?
Disease control By invitation onlyThis study looks at two antiviral drugs, TAF and TDF, in pregnant women with chronic hepatitis B. It aims to see which one better controls the virus and keeps the mother's liver healthy without harming the baby. About 816 women in early or middle pregnancy will take one of the dr…
Phase 4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a few shots replace weeks of IV antibiotics for joint infections?
Disease control OngoingThis study tests dalbavancin, a long-acting antibiotic given as a few shots over two months, for infections that occur after hip or knee replacement surgery. The standard treatment requires 12 weeks of daily antibiotics, which can be hard to tolerate and complete. The trial inclu…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Atacicept's Long-Term promise for kidney disease
Disease control By invitation onlyThis study looks at the long-term safety and effects of atacicept in people with IgA nephropathy, a kidney disease. Participants have already completed a previous trial with atacicept. Researchers will monitor side effects and measure kidney function over time to see if the drug …
Phase 2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Dissolving magnesium membrane could simplify dental implants
Disease control OngoingWhen a tooth is removed, the bone and gum often shrink, making it harder to place a dental implant later. This study tests a new magnesium membrane that is placed over a bone graft in the socket. Unlike standard membranes, it is rigid enough to protect the graft but dissolves on …
Sponsor: Martina Stefanini • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a formula diet reverse fatty liver damage?
Disease control OngoingThis study tests whether a special formula diet can help people with non-alcoholic fatty liver disease (NASH) lose weight and improve liver health. About 20 overweight adults will follow the diet to see if it reduces liver fat and scarring. The goal is to find a safe, effective w…
Sponsor: West German Center of Diabetes and Health • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Stem cells and 3D printing join forces to mend broken bones and arthritic knees
Disease control OngoingThis study tests a combination of a patient's own stem cells and platelet-rich plasma to help heal broken bones that won't mend on their own and to treat knee arthritis. For people needing a knee replacement, doctors use custom 3D-printed guides made from the patient's scans to i…
Sponsor: Zaporizhzhiya State Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug aims to slow kidney failure in common kidney disease
Disease control OngoingThis phase 3 trial tests whether the drug atrasentan can slow kidney function loss in people with IgA nephropathy, a disease that can lead to kidney failure. About 404 participants receive either atrasentan or a placebo, along with standard care. The main goal is to see if atrase…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy aims to slow lung scarring in hypersensitivity pneumonitis
Disease control OngoingThis phase 4 trial tests whether adding mycophenolate mofetil (MMF) to standard prednisolone treatment works better than prednisolone alone for fibrotic hypersensitivity pneumonitis, a lung condition where scarring makes breathing hard. About 144 adults with at least 40% predicte…
Phase 4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Hope for NASH: new pill aims to reverse liver damage and prevent cirrhosis
Disease control OngoingThis Phase 3 trial tests whether the drug resmetirom (MGL-3196) can reverse liver scarring (fibrosis) and stop NASH from progressing to cirrhosis or liver failure. About 1,759 adults with NASH and liver fibrosis will receive either resmetirom or a placebo daily for up to 54 month…
Phase 3 • Sponsor: Madrigal Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug aims to plug kidney leaks in multiple diseases
Disease control OngoingThis phase 2 study tests the drug atrasentan in 103 adults with various kidney diseases that cause protein leakage, including IgA nephropathy and FSGS. Participants take a daily tablet to see if it reduces protein in urine, a sign of kidney damage. The goal is to find a new way t…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Tiny gel particles may boost gum healing without surgery
Disease control OngoingThis study tests whether adding a special nano-gel (nano-hydroxyapatite) to a deep-cleaning gum treatment helps heal deep gum pockets better than cleaning alone. About 28 adults with advanced gum disease will be randomly assigned to get either the cleaning plus gel or just the cl…
Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New biologic drug netakimab tested in kids with psoriasis
Disease control OngoingThis phase 3 trial tests the drug netakimab in children aged 6 and older with moderate to severe plaque psoriasis. The study compares netakimab to a placebo and also includes an open-label group receiving adalimumab. The main goal is to see if netakimab improves skin symptoms, me…
Phase 3 • Sponsor: Biocad • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New RA pill takes on tofacitinib in Head-to-Head trial
Disease control OngoingThis phase 3 trial tests whether a new oral drug called TLL-018 works better than tofacitinib for active rheumatoid arthritis. The study includes 459 adults aged 18-65 who have not responded well to or cannot tolerate biologic treatments. Participants take either TLL-018 or tofac…
Phase 3 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a simple antiviral stop hepatitis b from waking up in lymphoma patients?
Disease control OngoingThis study tests whether the antiviral drug entecavir can prevent hepatitis B from reactivating in people with a type of blood cancer (CD20-positive B-cell lymphoma) who have had hepatitis B in the past but cleared it. The 84 participants will take entecavir before starting their…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could Immune-Boosting drugs treat certain psychosis?
Disease control OngoingThis phase 2 trial tests whether a combination of intravenous immunoglobulin (IVIG) and rituximab can help people with psychosis caused by antibodies attacking the brain. 70 participants with acute psychosis and specific antibodies receive either the immunotherapy or a placebo. T…
Phase 2 • Sponsor: University of Cambridge • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Promising pill may halt vitiligo and bring back pigment
Disease control OngoingThis phase 2 trial tests deucravacitinib, a daily pill that targets the immune system, to see if it can stop vitiligo from spreading and help skin regain its color. About 128 adults with non-segmental vitiligo will take the drug or a placebo for 24 weeks, then some will also rece…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could less steroid be just as good for kids with kidney disease?
Disease control OngoingThis study tests whether a lower dose of the steroid prednisone can treat relapses of nephrotic syndrome in children as effectively as the standard dose. Fifty children aged 1 to 18 with active relapses will be randomly assigned to either the reduced-dose or standard-dose regimen…
Phase 3 • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
At-Home light therapy could zap nail fungus
Disease control OngoingThis study tests a new home-use LED light device to treat nail fungus (onychomycosis). Researchers want to find the best light dose and how often to use it. Fifty adults with nail fungus will use the device at home and be monitored for improvement.
Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
One surgery instead of two? new coating may fight hip implant infections
Disease control OngoingThis study compares a single-stage surgery using implants coated with an antibiotic-loaded hydrogel to the standard two-stage surgery for treating chronic hip prosthesis infections. The single-stage approach aims to remove the infected implant and place a new one in the same oper…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New Blood-Clot monitor could cut transfusions in heart surgery
Disease control OngoingThis study tests whether a bedside device called Quantra can help doctors decide when to give blood transfusions during complex heart surgery. The device measures how well a patient's blood clots in real time. Researchers hope this will reduce the number of blood products (like r…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Study tests if one drug can replace two for inflammatory bowel disease
Disease control By invitation onlyThis study looks at whether using just one medication (infliximab) under the skin works as well as using it together with another immune-suppressing drug for people with Crohn's disease or ulcerative colitis. About 420 adults who have already started infliximab will be followed f…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Reishi mushroom tested as fatty liver treatment in new study
Disease control By invitation onlyThis study tests whether Ganoderma lucidum (a type of mushroom) can improve antioxidant levels and liver health in people with Metabolic Associated Fatty Liver Disease (MAFLD). Forty adults aged 35-49 with early-stage fatty liver will take the mushroom supplement. Researchers wil…
Sponsor: University of Agriculture, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo treatment for vitiligo shows promise in early trial
Disease control OngoingThis study tests whether injecting carbon dioxide gas (carboxytherapy) alongside standard narrowband UVB light therapy can improve repigmentation in people with stable vitiligo. Fifty-nine participants with symmetrical patches will receive whole-body UVB light, with carboxytherap…
Phase 4 • Sponsor: Kasr El Aini Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug shows promise for rare blood vessel disease
Disease control OngoingThis study tests a drug called tezepelumab in 42 adults with EGPA, a rare disease that causes inflammation in blood vessels and can damage organs. The goal is to see if the drug helps patients reach remission, meaning no active disease and low steroid use. Participants receive ei…
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New eye drop combo aims to soothe dry eyes fast
Disease control By invitation onlyThis study tests whether using two eye drops together—Vevye (cyclosporine) and Flarex (a steroid)—can safely improve symptoms in adults with moderate to severe dry eye disease. Sixty participants will use Vevye twice daily and Flarex four times daily for one month. The goal is to…
Phase 4 • Sponsor: Canyon City Eyecare • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Vitamin D3 as a Gut-Soothing sidekick for IBD patients?
Disease control PausedThis study tests whether adding high-dose vitamin D3 to standard anti-TNF therapy can improve symptoms and reduce inflammation in people with active Crohn's disease or ulcerative colitis. About 100 adults starting anti-TNF treatment will receive either vitamin D3 or a placebo for…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study pits scope against scalpel for pancreatic cleanout
Disease control CancelledThis study was designed to compare two ways to treat walled-off necrosis (a pocket of dead tissue) caused by severe pancreatitis. One method uses a scope through the mouth to clean out the pocket, the other uses surgery through the stomach. The goal was to see which approach work…
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Pregnancy hepatitis b drug showdown: which is safer for mom and baby?
Disease control By invitation onlyThis study tests two antiviral medications, TAF and TDF, in 200 pregnant women with chronic hepatitis B. The goal is to see which drug better prevents passing the virus to the baby and causes fewer birth defects or side effects. Participants take the drug daily during pregnancy a…
Phase 4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Better ankle implant aims to last longer and reduce pain
Disease control OngoingThis study follows 200 people who received a new type of ankle replacement designed to attach better to bone and wear out more slowly. Researchers will track pain, function, and how long the implant lasts over time. The goal is to see if this improved device helps people with sev…
Sponsor: Northumbria Healthcare NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New mouthwash takes on gum disease: could it beat the standard?
Disease control OngoingThis study tests whether a new mouthwash that repairs enamel and fights bacteria works better than a standard chlorhexidine mouthwash for treating gum disease. About 40 adults with mild to moderate gum disease will use one of the mouthwashes along with deep cleaning. The goal is …
Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Eczema drug trial could mean fewer shots for patients
Disease control OngoingThis study tests the drug lebrikizumab in 520 adults and teens (ages 12+) with moderate-to-severe eczema. Part 1 looks at how well the drug improves skin symptoms over 24 weeks. Part 2 compares a new dosing schedule (every 12 weeks) to the current one (every 4 weeks) to see if it…
Phase 3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to protect kidneys in IgA nephropathy patients
Disease control OngoingThis Phase 3 trial tests sparsentan, a new drug, against irbesartan (a standard treatment) in 406 adults with IgA nephropathy, a kidney disease. The goal is to see if sparsentan better protects kidney function over about 2 years. Participants must have significant protein in thei…
Phase 3 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Peer support after prison may boost hepatitis c care
Disease control OngoingThis study tests whether peer mentors—people with similar experiences—can help individuals recently released from jail or prison get connected to Hepatitis C care and stay in treatment. About 80 participants will either receive a peer mentor or standard referral. The goal is to s…
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New hope for HAE patients: experimental drug aims to slash attack rate
Disease control OngoingThis study tests an experimental drug called BW-20805 in 25 adults with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. The goal is to see if the drug can reduce how often attacks happen over about 6 months. Participants must have had at least 2 att…
Phase 2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug mimics natural protein to calm overactive immune system in nerve disease
Disease control OngoingThis Phase 2 trial is testing a new drug called NVG-2089 in 60 adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks nerves. The drug is designed to mimic a natural protein (IVIg) to reduce inflammation and improve nerve…
Phase 2 • Sponsor: Nuvig Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a single X-Ray tame COVID-19 lung inflammation?
Disease control OngoingThis phase 2 trial tests whether a single, low dose of radiation to the chest can reduce lung inflammation in hospitalized COVID-19 pneumonia patients. Researchers compare two radiation doses (35 cGy and 100 cGy) to standard care. The goal is to see if this treatment lowers the n…
Phase 2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Last-Resort treatment for joint infections now available
Disease control Expanded access (paused)This program provides access to the VT-X7 system, which delivers antibiotics directly into the joint through a pump over 7 days, for people with a serious hip or knee infection after joint replacement. It is for patients who have already tried other treatments and have no other o…
Sponsor: Osteal Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New study tests 2-Year dupilumab treatment for Kids' eczema
Disease control OngoingThis study looks at how well dupilumab (Dupixent) works over two years in about 48 children aged 6 to 14 with moderate-to-severe eczema. The main goal is to see if the drug improves the skin's barrier function, measured by water loss through the skin. All participants receive dup…
Phase 4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Dietary intervention aims to tame weight regain in Graves' patients
Disease control OngoingThis study tests whether a personalized low-calorie Mediterranean-style diet, combined with lifestyle coaching, can prevent people newly diagnosed with Graves' disease from regaining too much weight after their thyroid levels normalize. Fifty-four adults will be randomly assigned…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Pancreas removal plus islet transplant: a new hope for chronic pancreatitis pain?
Disease control OngoingThis study follows 433 people with chronic pancreatitis who undergo a surgery called TPIAT, where the entire pancreas is removed to stop pain and the patient's own insulin-producing islet cells are infused back to lower diabetes risk. Researchers track pain relief, quality of lif…
Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug shows promise for controlling rare kidney disorders
Disease control OngoingThis study tests the long-term safety and effectiveness of pegcetacoplan in 100 people with two rare kidney diseases, C3 glomerulopathy and IC-MPGN. Participants previously completed a one-year trial and saw benefit from the drug. The goal is to see if pegcetacoplan can keep redu…
Phase 3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New shoulder replacement system tracked in global study
Disease control By invitation onlyThis study is following 110 people who received a Tornier HRS shoulder replacement to see how well it improves pain and function. Participants have conditions like arthritis, fractures, or rotator cuff tears. The goal is to collect long-term safety and performance data for regula…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Breakthrough ear tube device could make surgery obsolete for kids
Disease control OngoingThis study tests a new device called Solo+ that places tiny tubes in the eardrums of children with ear infections. The goal is to see if it is safe and effective when done in a doctor's office instead of an operating room. About 66 children aged 6 months to 12 years will be enrol…
Sponsor: AventaMed DAC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Gene therapy aims to stop painful swelling attacks in hereditary angioedema
Disease control OngoingThis study tests a new treatment called NTLA-2002 for adults with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. The therapy uses gene editing to lower a protein that triggers these attacks. The goal is to see if it is safe and can reduce h…
Phase 1/2 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Bringing the hospital to your living room: a massive study tests home care for common illnesses
Disease control By invitation onlyThis study looks at whether treating patients at home for conditions like infections, heart failure, diabetes, and COPD can lead to better health outcomes and satisfaction compared to traditional hospital stays. Nearly 10,000 adults will receive hospital-level care at home, inclu…
Sponsor: OSF Healthcare System • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New knee implant tracked for 10 years – will it last?
Disease control OngoingThis study follows 148 people with knee osteoarthritis who received the ANTHEM total knee replacement system. Researchers will check how well the implant holds up over 10 years by measuring survival rates and patient-reported knee function. The goal is to confirm the device is as…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New knee replacement system under study for arthritis patients
Disease control OngoingThis study looks at how safe and effective the ANTHEM CR total knee system is for people with non-inflammatory degenerative joint disease who need a total knee replacement. About 153 participants will be followed for up to 10 years to check implant survival, bone health, and any …
Sponsor: Smith & Nephew Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a Double-Dose of antibiotics in bone cement prevent infections after hip surgery?
Disease control OngoingThis study compares two types of antibiotic-loaded bone cement used during hip fracture surgery to see which better prevents joint infections. About 7000 patients aged 60 and older with displaced femoral neck fractures will be included. Hospitals are randomly assigned to use eith…
Phase 3 • Sponsor: Umeå University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
CAR-T cells take on rheumatoid arthritis in Head-to-Head trial
Disease control OngoingThis phase I/II trial compares a single dose of CAR-T cell therapy (KYV101) to two doses of rituximab in 13 people with active, treatment-resistant rheumatoid arthritis. The main goals are to check safety and see if the CAR-T treatment can turn off certain immune markers linked t…
Phase 1/2 • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Glow-in-the-Dark mouth scans could catch cancer early
Diagnosis OngoingThis study tests whether special lights and cameras can help find early signs of mouth cancer in people at high risk. About 338 participants with precancerous spots or conditions like Fanconi anemia will have their mouths examined with fluorescence imaging, which makes abnormal c…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Can AI learn to spot kidney disease in biopsy images?
Diagnosis OngoingResearchers are building deep learning models that analyze digital images of kidney biopsy tissue to classify kidney diseases such as IgA nephropathy and membranous nephropathy. The study uses pathology images and clinical data from thousands of patients who had kidney biopsies a…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Breath and blood tests could revolutionize asthma diagnosis in kids
Diagnosis OngoingThis study is testing whether two simple, non-invasive tests—a breath test (FeNO) and a blood test (eosinophil count)—can accurately diagnose asthma in children aged 6 to 17. Currently, diagnosing asthma often requires complex hospital-based breathing tests. The researchers aim t…
Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Could women test for yeast infections at home? a swab test takes on the lab
Diagnosis OngoingResearchers are comparing the SavvyCheck Vaginal Yeast Test, a rapid swab test women use themselves, against standard vaginal yeast culture done in a lab. The study enrolls women with symptoms such as vaginal itching, discharge, soreness, or burning. The goal is to measure how ac…
Sponsor: Uniformed Services University of the Health Sciences • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
AI plus ultrasound could catch heart and lung decline before it turns critical
Diagnosis By invitation onlyResearchers are testing whether artificial intelligence can combine ultrasound images with routine health data to track changes in a person's physiology over time. The study enrolls adults with heart, lung, kidney, or blood vessel conditions, as well as healthy volunteers. The go…
Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
New test could spot hidden diabetes in pancreatic disease patients
Diagnosis OngoingThis study is testing a mixed meal test to better diagnose a specific type of diabetes (type 3c) that occurs in people with pancreatic cancer or chronic pancreatitis. Researchers will enroll 775 adults aged 30 to 84 who have new-onset diabetes and one of these pancreatic conditio…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
AI and blood biomarkers could catch hidden liver damage
Diagnosis OngoingThis study tests whether combining artificial intelligence with blood biomarkers can improve the detection of compensated advanced chronic liver disease (cACLD) in people with fatty liver disease. Researchers will enroll 408 adults with dysmetabolic liver disease and compare stan…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
AI as a second set of eyes: could it sharpen pneumonia detection on chest X-Rays?
Diagnosis OngoingThis trial tests whether an artificial intelligence system can help less-experienced doctors—like final-year medical students and early-career general practitioners—interpret chest X-rays more accurately. Participants will read the same set of X-rays twice: once with AI assistanc…
Sponsor: Universidad de la Sabana • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
New imaging tools put to the test for measuring dry eye treatment effects
Diagnosis OngoingThis study tests whether two specialized eye imaging devices—the LipiView II and Keratograph 5M—can detect changes in tear film stability after using Miebo eye drops in people with dry eye. Twenty adults with normal tear film will have their eyes measured before and at several ti…
Phase 4 • Sponsor: The Eye Care Institute • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
New ear scanner could slash unnecessary antibiotics in kids
Diagnosis OngoingThis study tests a device called OtoSight that helps doctors see inside a child's ear more clearly. The goal is to see if using it leads to fewer unnecessary antibiotic prescriptions, better outcomes, and lower costs. About 700 children aged 6 months to 17 years with ear pain are…
Sponsor: PhotoniCare, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Three extra minutes on an MRI could catch a deadly side effect of cancer treatment
Diagnosis OngoingThis study looks at whether adding just 3 minutes to a cardiac MRI can help doctors find heart inflammation (myocarditis) early in cancer patients on immunotherapy. Myocarditis is a rare but often deadly side effect of these drugs. The researchers will scan 200 patients who alrea…
Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Blood test breakthrough could end painful liver biopsies for NASH patients
Diagnosis OngoingThis study looks at whether two blood markers, PLIN2 and RAB14, can accurately diagnose NASH (a serious liver disease) and advanced scarring, without needing a liver biopsy. Researchers will test these markers in 828 adults with NASH, type 2 diabetes, or obesity. If successful, t…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to crack the code on hidden joint infections
Diagnosis OngoingThis study looks at 174 adults with painful joint replacements who may have a chronic infection. Researchers are testing a combination of advanced lab tests, imaging, and tissue sampling to see which methods best detect the infection. The goal is to create a more reliable diagnos…
Sponsor: University Hospital, Ghent • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New stool test could cut unnecessary colonoscopies
Diagnosis By invitation onlyThis study checks if a new stool test can better tell the difference between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) compared to current tests. About 300 adults and teens will give a stool sample and have a colonoscopy as part of their regular care. If…
Sponsor: DiaSorin Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Can a simple rinse stop the most painful complication of wisdom tooth surgery?
Prevention OngoingRemoving an impacted lower wisdom tooth can leave a painful complication called dry socket, where the protective blood clot in the empty socket breaks down. This trial compares two liquids used to rinse the socket right after extraction: normal saline and chlorhexidine, an antise…
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Turmeric compound tested to stop stomach cancer before it starts
Prevention OngoingThis study tests whether curcumin, a compound found in turmeric, can prevent stomach cancer in people with chronic atrophic gastritis or gastric intestinal metaplasia. About 50 participants will receive either curcumin or a placebo for a period, and researchers will measure chang…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
New drug aims to stop dangerous gut infection from returning
Prevention OngoingThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infection from coming back after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more pe…
Phase 2/3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Which vaccine schedule keeps children protected longest?
Prevention OngoingThis trial tests different vaccination schedules for Japanese encephalitis in healthy children starting at 8 months old. Researchers compare how well each schedule triggers and maintains protective antibodies through age 6, including the effect of booster doses. The study also mo…
Phase 4 • Sponsor: Liaoning Chengda Biotechnology CO., LTD • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Can a switch to goat milk formula prevent baby eczema?
Prevention OngoingThis trial compares two types of infant formula to see if one lowers the chance of developing eczema, also called atopic dermatitis. Researchers will enroll over 2,000 healthy full-term babies and feed them either a formula made from whole goat milk or one made from cow's milk. T…
Sponsor: Dairy Goat Co-operative (N.Z.) Limited • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Could everyday supplements shield your lungs?
Prevention OngoingThis trial is testing whether taking daily vitamin D3 and fish oil supplements can reduce the risk of lung problems like COPD flare-ups, asthma attacks, and pneumonia in older adults. It involves over 25,000 men and women aged 50 and older who do not have a history of cancer or h…
Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Exercise may shield Women's bones and joints after menopause
Prevention OngoingThis study tests whether a supervised resistance exercise program can reduce the risk of osteoporosis and osteoarthritis in women aged 50-70 who have gone through menopause. Participants will do leg and core exercises twice a week for 30-40 minutes. Researchers will measure chang…
Sponsor: Loughborough University • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Triple-Pronged attack on lung cancer: aspirin, smoking cessation, and lifestyle changes tested in new trial
Prevention OngoingThis study tests whether a combination of low-dose aspirin, a smoking cessation drug called cytisine, and guidance on diet and exercise can reduce chronic inflammation and lower lung cancer risk in heavy smokers aged 55 to 75. The 2000 participants will also receive annual low-do…
Phase 2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Simple knee device may speed up recovery after joint replacement
Symptom relief OngoingThis study tests whether a disposable device called the Zero Degree Knee positioner helps people regain full knee extension faster after total knee replacement surgery. About 154 adults aged 40-80 with knee osteoarthritis will be randomly assigned to use the device at home or fol…
Sponsor: Prisma Health-Midlands • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Custom knee guides put to the test in obese patients
Symptom relief OngoingResearchers are comparing two ways to perform total knee replacement in patients with obesity and knee arthritis. One method uses custom-made guides based on each patient's knee scans, while the other uses standard surgical tools. The trial measures how well the knee aligns, how …
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can everyday supplements boost gum disease therapy?
Symptom relief OngoingResearchers compare whether adding omega-3 or resveratrol supplements to standard non-surgical gum treatment improves periodontal health in healthy non-smokers with periodontitis. The study looks back at records from 60 patients split into three groups: those who took resveratrol…
Sponsor: Izmir Katip Celebi University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
3D printed inserts take on plantar fasciitis in new study
Symptom relief OngoingThis study tests whether 3D printed custom foot orthotics work as well as traditionally made ones for people with plantar fasciitis. About 30 adults with the condition will wear one type of insert for 8 weeks and report on comfort, fit, and pain relief. The goal is to see if the …
Sponsor: Prisma Health-Midlands • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a robotic exoskeleton rebuild arm strength after Guillain-Barré?
Symptom relief OngoingGuillain-Barré syndrome can leave people with weak arms and hands, making daily tasks hard. This trial tests whether adding robot-assisted arm training to usual therapy helps adults in the sub-acute phase of recovery. Participants use the Armeo Power 2 exoskeleton for 20 sessions…
Phase 4 • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
One shot, new knee? gene therapy trial aims to quiet arthritis pain
Symptom relief OngoingResearchers are testing FX201, an experimental gene therapy, in adults aged 30 to 80 with painful knee osteoarthritis. Participants receive a single injection of FX201 into the affected knee. The study first checks safety at increasing doses, then gives more people the same dose …
Phase 1 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a light device soothe canker sores?
Symptom relief CancelledResearchers are testing whether a low-level laser therapy device called Luminance RED can reduce pain and discomfort from recurrent canker sores. Adults who get canker sores at least once a month use the device at home and report daily pain and how hard it is to eat, drink, and b…
Sponsor: ProofPilot • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Mindful movement from home: new study targets knee pain without pills
Symptom relief OngoingThis study tests whether a 10-week telehealth program that combines gentle exercise with mindfulness can help people with knee osteoarthritis feel less pain and move better. Researchers will compare the mindful exercise group to an exercise-only group. All sessions happen remotel…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can cold exposure melt away liver fat?
Symptom relief OngoingResearchers test whether repeated cold exposure using a water-perfused cooling suit can reduce liver fat and improve liver health in adults with metabolic dysfunction-associated steatohepatitis (MASH). Eleven participants wear the suit for about two hours daily over three months.…
Sponsor: Renmin Hospital of Wuhan University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a hydrogel injection ease knee arthritis pain?
Symptom relief OngoingResearchers are observing people with knee osteoarthritis who receive an injection of Arthrosamid, a hydrogel, into the affected knee. The study follows about 200 adults over the long term to track side effects and changes in pain, stiffness, and physical function. Because it is …
Sponsor: Contura • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Steroid rinse inside the tooth: a new way to curb root canal pain?
Symptom relief OngoingThis trial compares two final rinses used during two-visit root canal treatment for adults with symptomatic irreversible pulpitis, a painful tooth infection. Participants receive either a dexamethasone solution or normal saline as the last rinse inside the root canal. Researchers…
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Spa therapy tested for knee arthritis relief
Symptom relief OngoingThis study looks at whether a 6-month thermal spa treatment program can meaningfully reduce pain and improve daily function in people with knee osteoarthritis. Researchers will compare results from 76 participants aged 50-80 who receive the spa therapy against an external group r…
Sponsor: CEN Biotech • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Robots take on knee surgery: could precision mean less pain?
Symptom relief OngoingThis study compares robotic-assisted total knee replacement to the standard manual procedure in 86 adults aged 40-85 with severe knee arthritis. Participants will receive the same knee implant, but one group's surgery is guided by a robotic system. Researchers will measure pain, …
Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a Job-Focused rehab program keep arthritis patients employed?
Symptom relief OngoingPeople with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis often struggle to stay in work. This trial tests a 6-month vocational rehabilitation program called WORK-ON, which includes a coordinating occupational therapist, group sessions with peers, and ind…
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can virtual walking trick the brain into easing chronic pain?
Symptom relief OngoingResearchers are testing whether a virtual walking program can reduce chronic pain and psychological distress in people with severe mobility impairment, mostly from spinal cord injuries or polio. Participants wear a head-mounted display and use a controller to guide an avatar thro…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Shock waves could soothe sore knees without surgery
Symptom relief CancelledThis study tests whether adding shock wave therapy to a knee strengthening exercise program reduces pain and improves function more than exercise alone in people with knee osteoarthritis. Forty patients with moderate knee pain will be randomly assigned to either exercise only or …
Sponsor: Guadarrama Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Massage gun vs. hands: which eases Post-Hip-Surgery numbness?
Symptom relief By invitation onlyAfter hip replacement through a front incision, many people feel numbness, tingling, or burning in the thigh because a nearby nerve gets irritated. This trial tests whether a handheld massage gun, used at home twice a day for six weeks, can ease those symptoms faster than gentle …
Sponsor: Zachary M Ricciardelli • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New study tests better ways to clean teeth during root canal retreatment
Symptom relief OngoingThis study looks at three different methods to activate cleaning fluids during root canal retreatment: ultrasonic, sonic, and laser. The goal is to see which one causes the least pain and helps the infection heal best. Seventy-five adults with previously treated teeth that still …
Sponsor: Ege University • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Mouth device aims to keep Sore-Relief rinses where They're needed
Symptom relief CancelledResearchers are testing a new medical device called Bocaliner in people who have painful mouth sores caused by chemotherapy or radiation. The device is held in the mouth after using medicated mouthwashes, gels, or rinses, with the goal of keeping those treatments in contact with …
Early phase 1 • Sponsor: E2Bio Life Sciences, LLC • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Green tea compounds could soothe radiation burns in cancer care
Symptom relief By invitation onlyThis Phase 3 trial tests whether catechins (compounds found in green tea) given as a pill or spray can prevent or treat skin damage caused by radiation therapy. About 162 cancer patients will receive either catechins or a placebo, alongside standard care. The goal is to see if th…
Phase 3 • Sponsor: CARLOS FRANCISCO SAAVEDRA GARCIA • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can an Off-the-Shelf insole tame stubborn heel pain?
Symptom relief OngoingResearchers are studying whether a pre-made plantar insole, designed by shoe size and gender, helps adults with plantar fasciitis that has lasted at least six months and resisted other treatments. About 25 people will wear the insole during everyday walking for one year. The team…
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
A personal nurse and a plan: could this ease the daily burden of arthritis?
Symptom relief OngoingThis trial tests a six-month program where a coordinating rheumatology nurse helps people with inflammatory arthritis set goals and plan actions to manage their condition. Participants also get access to physiotherapy, occupational therapy, and social work support as needed. The …
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
New natural gel for bacterial vaginosis passes first safety check
Symptom relief OngoingThis early-stage study tests whether LCFA-01, a natural gel containing oleic acid, is safe and comfortable when placed in the vagina. Thirty healthy women aged 18-40 will use the gel and be monitored for side effects, discomfort, and how much of the product enters the bloodstream…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Hip replacement showdown: does the labrum stay or go?
Symptom relief By invitation onlyResearchers are comparing two common surgical approaches during total hip replacement: removing the acetabular labrum (a ring of cartilage around the hip socket) or leaving it in place. The trial enrolls 200 adults with hip osteoarthritis who are scheduled for a primary unilatera…
Sponsor: Total Joint Specialists • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Seaweed supplement shows promise for cancer-related fatigue in small pilot trial
Symptom relief OngoingThis pilot study tests whether taking a seaweed supplement called fucoidan for 8 to 16 weeks can reduce fatigue and inflammation in cancer survivors. Researchers will enroll 40 adults who have completed cancer treatment within the last 10 years and still feel tired. The main goal…
Phase 2 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Gum health showdown: video vs. Hands-On training – which works better?
Symptom relief CancelledThis study tested two ways to teach people with gingivitis (early gum disease) how to clean their teeth better. One group watched a video, the other practiced on a dental model. After one month, both groups showed improved gum health and awareness, with no major difference betwee…
Sponsor: Ankara University • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Could a simple drink help clear confusion in hospitalized seniors?
Symptom relief OngoingThis study tests a proprietary amino acid drink given twice daily for up to 4 days to older adults (60+) hospitalized with infections who have delirium. 20 participants get the drink, 20 get standard care, and 20 non-delirious controls are observed. The goal is to see if the drin…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Sensor-Aided rehab could transform knee replacement recovery
Symptom relief OngoingThis trial tests whether a wearable sensor that monitors home exercises helps people recover after total knee replacement. Researchers randomly assign 250 adults to either use the sensor or receive standard unsupervised home exercises. The study compares knee function, pain, and …
Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief OngoingThis study tests an experimental drug called APG777 in 470 adults with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with creams. The goal is to see if the drug safely reduces skin redness, itching, and rash. Participants receive either APG777 or a placebo fo…
Phase 2 • Sponsor: Apogee Therapeutics, Inc. • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Stretch device vs. physical therapy: which loosens a frozen shoulder?
Symptom relief OngoingResearchers are comparing three ways to treat shoulder stiffness: physical therapy alone, the ERMI Shoulder Flexionater stretch device alone, and the device plus physical therapy. The trial includes people with frozen shoulder (adhesive capsulitis), people with stiffness after sh…
Sponsor: Foundation for Orthopaedic Research and Education • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Eye drops take aim at dry eye: phase 2 trial puts TJO-087 to the test
Symptom relief OngoingResearchers are testing an experimental eye drop called TJO-087 in adults with dry eye syndrome. The trial enrolls about 90 people who have dry eye symptoms and signs of corneal damage. Participants receive either TJO-087 or a placebo drop for 3 months. The main measure is whethe…
Phase 2 • Sponsor: Taejoon Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a smarter oxygen device help lung disease patients move more?
Symptom relief By invitation onlyThis study tests whether using a portable oxygen concentrator (a lightweight, battery-powered device) during walking or exercise helps people with interstitial lung disease (ILD) or COPD feel less breathless and be more active in their daily lives. Twenty-four participants will t…
Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Which exercise heals the knee tendon best? a Head-to-Head trial
Symptom relief By invitation onlyThis study compares two 12-week exercise programs—eccentric training and heavy-slow resistance training—in 30 adults aged 18–50 with patellar tendinopathy (knee pain lasting over 3 months). Researchers measure changes in tendon thickness, stiffness, strength, and pain to see whic…
Sponsor: University of Graz • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Gut health fix for aching knees? probiotic trial launches
Symptom relief OngoingThis study tests whether taking probiotic supplements for 6 months can reduce pain, improve knee function, and boost quality of life in women aged 45-70 with knee osteoarthritis. Researchers will compare the probiotic group to a placebo group to see if the gut bacteria help lower…
Sponsor: Lund University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Exercise may ease IBD symptoms in children, new study hopes to prove
Symptom relief OngoingThis study explores whether physical activity and fitness can reduce inflammation and improve quality of life in children aged 6 to 17 with Crohn's disease or ulcerative colitis. Researchers will track 100 participants over time and test a 12-week supervised exercise program. The…
Sponsor: Universidad Complutense de Madrid • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can a tiny catheter cut opioid use after knee surgery?
Symptom relief OngoingThis study compares two ways to manage pain after total knee replacement: a continuous nerve catheter that delivers numbing medicine for days versus a single nerve block. Sixty-four adults scheduled for knee surgery will be randomly assigned to one of the two methods. Researchers…
Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New allergy shot aims to tame dust mite misery
Symptom relief OngoingThis early-stage trial tests a new biologic drug called ASP2390, given as a skin injection, in 28 adults with house dust mite allergies. The main goal is to check safety and how the immune system responds, not yet whether it works. If successful, it could lead to a new way to eas…
Phase 1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Sound waves vs. teen knee pain: a new test
Symptom relief OngoingThis trial tests whether shockwave therapy can improve knee function, balance, and fear of movement in adolescents with patellar tendinopathy, a common overuse injury causing knee pain. Fifty teens with pain in one knee will receive low-energy shockwaves to the tendon and thigh m…
Sponsor: Ahmed Alshimy • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New injection could ease knee arthritis pain without surgery
Symptom relief OngoingThis study tests whether an injected drug called pentosan polysulfate sodium can reduce knee pain and improve function in people with knee osteoarthritis. About 466 adults with moderate to severe knee arthritis who haven't found relief from other treatments will receive either th…
Phase 3 • Sponsor: Paradigm Biopharmaceuticals Ltd. • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New drug aims to ease heart failure symptoms in inflamed patients
Symptom relief OngoingThis study tests a new medicine called ziltivekimab in 680 adults with heart failure and signs of inflammation. Participants will receive either the drug or a placebo for up to 16 months. The goal is to see if the drug improves heart failure symptoms and physical function, like b…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Promising drug may ease painful genital psoriasis
Symptom relief OngoingThis study tests an injected drug called tildrakizumab for people with moderate to severe genital psoriasis. About 206 adults will receive either the drug or a placebo to see if it clears skin and reduces itching. The goal is to improve comfort and quality of life in this sensiti…
Phase 3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Knee patients try personalized goal program to boost treatment success
Symptom relief OngoingThis study tests a goal-setting program for adults with knee problems like arthritis or injuries. Participants work with their surgeon to create specific, measurable goals and track progress. The aim is to see if this approach helps patients achieve their treatment goals and impr…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Knee injection during surgery may ease arthritis pain
Symptom relief OngoingThis study tests whether an extended-release steroid injection (Zilretta) given during knee meniscus surgery can reduce pain and inflammation in people with osteoarthritis. 150 adults aged 40 and older are enrolled. Researchers will measure knee pain scores and inflammatory marke…
Phase 4 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
COPD patients may breathe easier by switching to heated tobacco
Symptom relief OngoingThis study looks at whether people with COPD and chronic bronchitis who switch from regular cigarettes to a tobacco heating system feel better and breathe easier. About 290 adults aged 40 and older who have smoked for at least 10 years will take part. Researchers will measure cou…
Sponsor: Philip Morris Products S.A. • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Antibiotics may not be needed for mild diverticulitis, new US trial suggests
Symptom relief CancelledThis trial tests whether people with mild diverticulitis can be safely treated at home with just pain medicines (ibuprofen and acetaminophen) instead of antibiotics. 556 participants will be randomly assigned to receive either pain medicines alone or pain medicines plus an antibi…
Phase 4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
A pocket coach for aching joints: can an app nudge osteoarthritis patients toward more activity?
Symptom relief OngoingThis study tests whether a smartphone app called PIANISSIMO can encourage people with osteoarthritis to be more physically active. Participants set weekly step goals and receive daily notifications about physical activity and its benefits for joint health. The trial focuses on wh…
Sponsor: Luxembourg Institute of Health • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can a new dental cement ease pain after Tooth-Saving treatment in kids?
Symptom relief OngoingThis trial tests whether two dental cements, MTA and CIMMO DTA®, differ in reducing pain after a pulpotomy—a procedure that removes the inflamed pulp inside a tooth—in children aged 6 to 16 with molar-incisor hypomineralization (MIH), deep decay, and irreversible pulpitis. Partic…
Sponsor: Meire Coelho Ferreira • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a gel or nanoparticles tame tooth pain after pulp treatment?
Symptom relief OngoingThis trial tests whether using sodium hypochlorite as a gel or solution, with or without tiny nanoparticles, affects pain after a pulpotomy—a procedure that removes the inflamed pulp inside a tooth. Adults aged 15 to 40 with severe pulpitis in a lower molar will be randomly assig…
Sponsor: Future University in Egypt • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
App-Based therapy aims to tackle knee pain without pills
Symptom relief OngoingThis study tests whether a digital therapeutic called MORA Cure can reduce knee pain in adults over 50 with knee osteoarthritis and anterior knee pain. Participants use a mobile app for 8 weeks that provides personalized exercises and cognitive behavioral therapy content. The app…
Sponsor: EverEx Inc. • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Chilling the root: could cryotherapy cool Post-Dental pain?
Symptom relief By invitation onlyThis trial tests whether applying cryotherapy (cold therapy) along with different concentrations of sodium hypochlorite irrigation during vital pulp therapy can reduce post-operative pain in permanent mandibular molars. Adults aged 15-40 with symptomatic irreversible pulpitis wil…
Sponsor: Future University in Egypt • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can an arthritis drug quiet the pain of chronic pancreatitis?
Symptom relief OngoingThis trial tests whether tocilizumab, an anti-inflammatory drug used for arthritis, can reduce pain and improve quality of life in people with chronic pancreatitis. Participants receive either tocilizumab or a placebo every four weeks for 24 weeks. The study measures changes in p…
Phase 2 • Sponsor: Soren Schou Olesen • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a Mind-Body program ease knee pain and lift mood?
Symptom relief OngoingThis study tests whether a 10-week program called Positive Minds, Strong Joints is feasible for Black adults aged 50 and older with knee osteoarthritis. The program combines recommended exercise with mental health strategies to address pain, depression, and anxiety. Researchers w…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a lotion outperform standard gel for knee pain?
Symptom relief OngoingThis phase II trial is testing whether an experimental lotion called ASKC200 can reduce pain in people with knee osteoarthritis. About 175 adults aged 40 to 80 with knee pain lasting at least six months will be randomly assigned to receive one of two strengths of ASKC200, a stand…
Phase 2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Beyond the heel: Whole-Leg training may ease achilles tendon pain
Symptom relief OngoingThis trial tests whether a rehabilitation program that exercises the entire leg — from foot to hip — can improve balance, reduce pain, and restore function better than standard tendon-focused exercises in people with chronic Achilles tendinopathy. Fifty adults aged 18 to 45 with …
Sponsor: May University in Cairo • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Turmeric and blue light may heal blisters in rare skin disease
Symptom relief OngoingThis study tests whether a gel made from curcumin (the active part of turmeric) combined with blue LED light can heal painful mouth blisters in people with epidermolysis bullosa, a rare condition that makes skin and mucous membranes extremely fragile. Twenty participants will rec…
Phase 4 • Sponsor: Universidade Ceuma • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New gel injection could ease arthritic knees
Symptom relief OngoingThis study tests a single injection of Hydrogel OA 2% in 20 adults with knee osteoarthritis. The goal is to see if the gel is safe and tolerable over 13 weeks to 12 months. Participants must be 35–75 years old with a BMI between 20 and 35.
Sponsor: Allegro NV/SA • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Which Non-Surgical treatment eases shoulder calcium pain best?
Symptom relief PausedThis study compares three non-surgical treatments—exercise therapy, shockwave therapy, and ultrasound-guided irrigation—against a wait-and-see approach for people with painful calcium deposits in the shoulder. About 116 participants with confirmed calcific tendinopathy will be ra…
Sponsor: University of Valencia • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New drug aims to spare cancer patients from debilitating mouth sores
Symptom relief OngoingThis phase 2 trial tests whether the drug RRx-001 can prevent severe oral mucositis (painful mouth sores) in 216 patients with head and neck cancer receiving standard chemoradiation. Patients are randomly assigned to receive RRx-001 or a placebo alongside their usual treatment. T…
Phase 2 • Sponsor: EpicentRx, Inc. • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Shockwave or laser: which zaps plantar fasciitis pain best?
Symptom relief OngoingThis study compares two non-invasive treatments—extracorporeal shock wave therapy and high-intensity laser therapy—for chronic plantar fasciitis, a common cause of heel pain. Sixty adults will receive one of the treatments plus standard physical therapy. Researchers will measure …
Sponsor: Ibrahim Abuomar Fadulaalhq Alramadhani • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Robot vs robot: which knee surgery system wins?
Symptom relief By invitation onlyThis study compares two robotic-assisted systems (Velys J&J and Cori S&N) for total knee replacement in 200 people with severe knee arthritis. Researchers will measure knee alignment, movement, and patient-reported outcomes like pain and function. The goal is to see if one robot …
Sponsor: Jan Biziel University Hospital No 2 in Bydgoszcz • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a magnetic helmet ease bladder pain? new study investigates
Symptom relief OngoingThis study tests whether a non-invasive magnetic brain stimulation technique, called rTMS, can reduce pain in women with interstitial cystitis or bladder pain syndrome. The treatment targets brain areas that control pelvic floor muscles, aiming to lower pain by improving how the …
Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New knee shot aims to ease arthritis pain in early trial
Symptom relief By invitation onlyThis early-stage trial tests an experimental drug called RAB001, given as an injection into the knee joint, for people with knee osteoarthritis. The study includes 60 participants aged 40 to 75 who have persistent knee pain despite conservative treatments. Researchers are primari…
Phase 1 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Which stretch wins? new study tests two neck pain therapies Head-to-Head
Symptom relief OngoingThis study compares two manual therapy techniques—Reciprocal Inhibition and Passive PNF Stretching—for people with chronic neck pain from cervical spondylitis. Sixty participants will receive 12 sessions over 4 weeks. Researchers will measure pain, disability, and neck movement t…
Sponsor: University of Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could a diet tame chronic hives in children?
Symptom relief By invitation onlyThis trial investigates whether a low-histamine and pseudoallergen-free diet can reduce symptoms like hives and itching in children aged 1 to 18 with chronic spontaneous urticaria. Participants follow the diet for 4 weeks while continuing standard care. Researchers track changes …
Sponsor: Istanbul University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Bee glue to the rescue? propolis ointment tested for dry skin
Symptom relief OngoingThis study tests whether ointments made from propolis, a natural substance from honeybees, can improve dry, itchy skin in adults with atopic tendencies. Thirty participants will apply either a propolis ointment or a plain base ointment twice daily for four weeks. Researchers will…
Sponsor: Manara University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Could a seizure drug ease pancreatitis pain and reduce opioid side effects?
Symptom relief OngoingThis early-phase trial tests whether adding lacosamide, a drug normally used for seizures, can safely help people with chronic pancreatitis who still have abdominal pain despite taking opioids. The study involves 21 adults who will take lacosamide for 7 days alongside their usual…
Phase 1 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New study tests which therapy works best for heel pain
Symptom relief By invitation onlyThis study compares two treatments for plantar fasciitis, a common cause of heel pain. About 56 adults with heel pain for at least 6 weeks will receive either instrument-assisted soft tissue mobilization or manual massage. Researchers will measure pain, daily function, and walkin…
Sponsor: Ibadat International University, Islamabad • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New stretching method may unfreeze stiff shoulders
Symptom relief PausedThis study tests a new physical therapy approach for people with frozen shoulder (stage 2 or 3). The technique combines specific stretches with shoulder mobilization. Researchers will measure improvements in shoulder movement and daily function. The trial is currently on hold.
Sponsor: Haytham M Elhafez • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Knee replacement pain study: which injection works best?
Symptom relief By invitation onlyThis study compares two methods of giving the pain medicine EXPAREL during knee replacement surgery. About 40 adults will receive the medicine either as a targeted block or as local infiltration. Participants will report their pain levels and any extra pain medicines they need. T…
Phase 4 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can an online course keep arthritis patients working?
Symptom relief OngoingThis study tests an online program designed to help people with inflammatory arthritis remain employed. The program includes eLearning modules, group video sessions, and consultations with an occupational therapist and vocational counselor. About 528 participants from three Canad…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Knee pain relief without pills? study tests exercise and Anti-Inflammatory diet
Symptom relief OngoingThis study tests whether a combination of a structured exercise program and a plant-based anti-inflammatory diet (the New Nordic Diet) can improve quality of life for people with mild to moderate knee osteoarthritis. Sixty participants will follow the training and diet plan, and …
Sponsor: St. Pölten University of Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New study aims to cut opioid use after joint replacement
Symptom relief OngoingThis study tests whether adding ultrasound-guided nerve blocks before hip or knee replacement surgery can reduce pain and opioid use compared to standard pain management. 400 adults with osteoarthritis will be enrolled. The goal is to improve recovery and reduce side effects like…
Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Can Ultrasound-Guided shots use less steroid for knee pain?
Symptom relief By invitation onlyThis study looks at whether a smaller dose of steroid injected into the knee with ultrasound guidance works as well as a larger dose given without ultrasound. The goal is to reduce side effects while still easing pain. About 140 people with knee osteoarthritis will receive one of…
Phase 4 • Sponsor: Sosi Dzhugarian • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
ThyMoves study: exercise may ease thyroid symptoms and prevent falls in seniors
Symptom relief By invitation onlyThis study looks at whether a tailored exercise program can improve quality of life, muscle strength, and balance in women aged 65 and older with Hashimoto's thyroiditis or multinodular toxic goiter. Participants will be randomly assigned to either the exercise program or usual c…
Sponsor: Aalborg University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Knee gel injection trial pulled before it began
Symptom relief CancelledThis study was designed to test whether a new gel called Hydrogel OA 2% could safely relieve knee osteoarthritis pain better than a standard treatment. It planned to enroll adults with knee OA and give them one injection, then track side effects and symptom improvement for 26 wee…
Sponsor: Allegro NV/SA • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could a simple tourniquet change cut Post-Surgery pain and opioid use?
Symptom relief OngoingThis study tests whether using a lower-pressure tourniquet during orthopedic surgeries can reduce pain and the need for opioid painkillers afterward. Standard tourniquets use high pressure, which can cause muscle weakness and pain. The experimental device sets pressure based on t…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Pregnancy gum woes? study tests best toothbrush for you
Symptom relief By invitation onlyThis study looks at whether sonic electric toothbrushes or manual toothbrushes are better at reducing gum inflammation in pregnant women. Gum problems are common during pregnancy due to hormone changes. The trial will follow 120 pregnant women aged 18-40 to see which toothbrush t…
Sponsor: Claude Bernard University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Vibration training may ease knee pain and boost mobility in seniors
Symptom relief By invitation onlyThis study looks at whether whole-body vibration training can improve body composition, muscle strength, walking speed, and pain in 30 older adults with knee osteoarthritis and sarcopenic obesity. Participants will do vibration exercises, and researchers will measure changes in p…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
One shot could ease knee pain for a year: new hydrogel tested
Symptom relief OngoingThis study tests a single injection of Arthrosamid, a hydrogel made mostly of water, in 29 people with painful knee osteoarthritis. The goal is to see if it improves daily activity and reduces symptoms over 12 months. Participants wear an activity tracker to measure changes, and …
Sponsor: Medisch Centrum Latem • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can remote rehab help lung patients breathe easier?
Symptom relief OngoingThis pilot study tests whether home-based or video-supervised exercise programs are acceptable and helpful for people with chronic lung diseases like IPF, sarcoidosis, bronchiectasis, asthma, and other interstitial lung diseases. Fifty participants will be randomly assigned to on…
Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Brain scans reveal secrets of lost smell
Knowledge-focused By invitation onlyThis study tracks 80 adults with different smell disorders (like total loss, partial loss, or distorted smell) plus healthy volunteers over one year. Researchers use brain scans, smell tests, and questionnaires to see how the brain changes and how smell loss impacts mood and dail…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Mouth microbes linked to artery damage in new study
Knowledge-focused By invitation onlyResearchers at Semmelweis University are studying whether bacteria that cause gum disease also show up in damaged blood vessels. They will compare samples from the mouth and from diseased artery sites in 100 people who need surgery for aortic aneurysm or carotid artery narrowing.…
Sponsor: Semmelweis University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Antibiotics alone or surgery? study tracks which endocarditis patients fare better
Knowledge-focused OngoingInfective endocarditis is an infection of the heart's inner lining or valves. About half of patients need surgery during their hospital stay, while others receive antibiotics alone. Researchers are following 1,046 adults with confirmed endocarditis for up to 24 months to compare …
Sponsor: Centro Cardiologico Monzino • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists dig into tissue samples to unravel lung scarring mystery
Knowledge-focused OngoingThis study collects and analyzes blood, DNA, and tissue samples from 315 adults with pulmonary fibrosis, their relatives, and healthy volunteers. The goal is to learn more about the disease's causes, not to test a new treatment. Researchers hope the findings will guide future the…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists spy on Lungs' first response to fake infection
Knowledge-focused By invitation onlyThis study looks at how healthy lungs respond to a substance called endotoxin, which mimics a bacterial infection. Researchers will collect lung cells and fluid from 58 healthy, non-smoking adults using a thin tube inserted into the airways. The goal is to understand inflammation…
Phase 2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can shedding pounds reshape the legs? a study tracks joint alignment after Weight-Loss surgery
Knowledge-focused OngoingThis observational study follows adults with morbid obesity who undergo bariatric surgery to see if substantial weight loss changes the alignment of their hips, knees, and ankles. Researchers measure leg alignment using standing X-rays before surgery and at 3, 6, and 12 months af…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Kidney biopsies probed for scarring signal in lupus
Knowledge-focused OngoingResearchers at Ain Shams University are examining kidney biopsy tissue from 30 adults with lupus nephritis to see whether a protein called TGF-beta is present and how it relates to kidney scarring, disease activity, and chronic damage. Participants undergo a standard ultrasound-g…
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
500-Person study aims to crack the code of personalized weight loss
Knowledge-focused By invitation onlyThis study follows 500 obese adults to see how different factors like diet, exercise, stress, and sleep affect weight loss. Researchers collect blood tests, measurements, and questionnaires at the start and during follow-up. The goal is to find patterns that could lead to more pe…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can wearable sensors and walking tests reliably track nerve damage?
Knowledge-focused OngoingResearchers are checking whether tests of muscle strength, walking, balance, and fine motor skills give consistent results in people with polyneuropathy. About 520 adults with various forms of nerve damage, plus healthy volunteers, take part. Participants complete physical tests,…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New study hopes to outsmart pancreatic cancer by gathering clues
Knowledge-focused OngoingThis study collects health information and test results from 317 people at high risk for pancreatic cancer, including those with cysts, genetic syndromes, or other risk factors. Researchers aim to build a database to find better ways to detect the disease early or prevent it. No …
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can coaching turn rural clinics into One-Stop shops for addiction and infectious disease care?
Knowledge-focused OngoingResearchers are testing a coaching program to help primary care clinics in rural West Virginia screen and treat opioid use disorder, HIV, and hepatitis C. The program includes group priority-setting, rapid-cycle improvement coaching, and provider training. Twenty clinics will tak…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
AI chatbot aims to ease tough choices for osteoarthritis patients
Knowledge-focused OngoingThis study tests whether an AI chatbot can help people with hip or knee osteoarthritis feel less conflicted and anxious about their treatment choices. About 100 adults with osteoarthritis will chat with the AI before seeing their surgeon. Researchers will measure changes in decis…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
When the immune system Can't fight back: tracking three respiratory viruses
Knowledge-focused OngoingResearchers are reviewing medical records from a large hospital network in Buenos Aires to understand what happens to adults with severely weakened immune systems after they catch RSV, influenza, or SARS-CoV-2. The study covers 350 patients and looks at how sick they were at diag…
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Registry maps the return of a stubborn heart condition
Knowledge-focused OngoingResearchers are building a registry to follow adults with recurrent pericarditis, a condition where inflammation around the heart keeps coming back. The registry collects information over time on how often flare-ups happen, what treatments patients receive, and whether they are h…
Sponsor: Eurasian Association of Therapists • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New tool measures how knee surgery affects emotional health
Knowledge-focused OngoingThis study aims to validate a new questionnaire that measures emotional wellbeing and patient perceptions after total knee replacement surgery for knee arthritis. Researchers will enroll 167 adults who had knee replacement within the last 3 months. The goal is to ensure the quest…
Sponsor: Invibio Ltd • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Essential oils put to the test: do they really support immunity?
Knowledge-focused OngoingThis study will test whether using essential oils (by smelling, applying to skin, or swallowing capsules) can improve immune health in healthy adults aged 18 to 45. Forty participants will use either the oils or a placebo for 30 days. Researchers will measure changes in blood, sa…
Sponsor: dōTERRA International • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gut fungi linked to lung trouble in HIV patients
Knowledge-focused OngoingThis study looks at whether fungi moving from the gut into the blood can cause inflammation and worsen lung function in people with HIV. Researchers will measure a fungal marker called BDG in blood and urine, and track lung health over three years. The goal is to better understan…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Cured of hepatitis c? this study follows patients for 10 years to see what happens next
Knowledge-focused OngoingThis study follows 121 adults who have been cured of chronic hepatitis C to understand why some still develop liver complications like scarring or cancer. Participants are monitored for up to 10 years with regular tests, scans, and occasional liver biopsies. The goal is to learn …
Phase 4 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
PRP knee injections: new study looks at blood protein changes in osteoarthritis patients
Knowledge-focused OngoingThis study tests whether platelet-rich plasma (PRP) injections into the knee can change certain proteins in the blood of people with knee osteoarthritis. About 60 participants aged 18-70 will receive either PRP or a saltwater placebo, and researchers will compare protein levels t…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Parkinson's drug may impact gum disease risk
Knowledge-focused OngoingThis study looks at whether the Parkinson's drug Levodopa-Benserazide affects gum health and inflammation. Researchers will measure gum health and saliva markers in 136 people, including Parkinson's patients with and without gum disease, and healthy controls. The goal is to under…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a thousand patient records unlock better care for a rare lung disease?
Knowledge-focused OngoingResearchers are assembling a large group of adults with idiopathic pulmonary fibrosis (IPF), a progressive lung disease, to support future patient-centered studies. The team will combine electronic health records with patient-reported outcomes from clinics at several academic med…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can tailored rehabilitation ease common childhood illnesses in uzbekistan?
Knowledge-focused By invitation onlyResearchers in Uzbekistan are studying common respiratory and heart conditions in children from birth to age 15. They will analyze medical records and examine blood samples to understand immune and antioxidant function in affected children. The goal is to develop and test improve…
Early phase 1 • Sponsor: Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Simple cord blood test may detect fetal infection early
Knowledge-focused OngoingThis study looks at whether measuring IL-6 and lactate in cord blood can detect early signs of infection or inflammation in full-term newborns. Researchers will compare 160 women whose fetal heart rate patterns suggest possible inflammation with those whose patterns are normal. I…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New skin scanner could reveal hidden changes in eczema treatment
Knowledge-focused OngoingThis study tests whether a special microscope (reflectance confocal microscopy) can detect skin changes in people with moderate-to-severe eczema who are taking tralokinumab. The drug blocks a protein involved in inflammation and is already known to help eczema. Researchers want t…
Sponsor: Hôpitaux Drôme Nord • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Shoulder implant safety tracked for years after surgery
Knowledge-focused OngoingThis study follows 76 people who received a pyrocarbon shoulder implant to see how well it works and holds up over 5 to 10 years. Researchers measure shoulder pain, function, and any complications. The goal is to confirm the implant is safe and effective for long-term use.
Sponsor: Stryker Trauma and Extremities • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can knee cartilage reveal why osteoarthritis worsens?
Knowledge-focused By invitation onlyThis study examines cartilage from people undergoing total knee replacement for osteoarthritis. Researchers will use a microscope to look at cell health, mitochondria, and autophagosomes, which are parts of cells involved in cleaning up damage. The goal is to better understand ho…
Sponsor: Yunnan University of Chinese Medicine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Massive medicare study aims to improve joint replacement safety
Knowledge-focused OngoingThis study looks at records from over 500,000 Medicare beneficiaries with rheumatoid arthritis or ankylosing spondylitis who had major orthopedic procedures like joint replacements or spine surgery between 1999 and 2015. Researchers want to understand how often complications happ…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New hip stem under the microscope: will it last?
Knowledge-focused OngoingThis study looks at how well a new hip replacement stem (Insignia) fits and stays in place over time. Researchers will review X-rays from 100 adults getting a first-time hip replacement to check for any signs of loosening. The goal is to see if the stem is safe and effective for …
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Will a new drug form work the same? study tests two versions of SKI-O-703
Knowledge-focused OngoingThis study tests whether two different capsule forms of the experimental drug SKI-O-703 are absorbed similarly in the body. About 48 healthy adults (Korean and Caucasian) will take a single dose of each form on separate days, with blood samples taken to compare drug levels. The r…
Phase 1 • Sponsor: Oscotec Inc. • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a stimulated muscle biopsy untangle two similar nerve and muscle diseases?
Knowledge-focused OngoingResearchers are testing a muscle biopsy method that uses mild electrical stimulation to sample the junction where nerves meet muscle. The goal is to see if this technique helps distinguish between inclusion body myositis and motor neuron disease, which can look alike. The study i…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Gene hunt aims to unlock secrets of lung scarring
Knowledge-focused OngoingThis study looks at lung tissue from 80 people with pulmonary fibrosis to find unique genetic markers linked to scarring. By analyzing gene activity, researchers hope to better understand the disease and pave the way for new diagnostic tools and treatments. Participants must be 1…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
AI takes on esophageal cancer: could it spot the disease earlier?
Knowledge-focused By invitation onlyThis study is testing whether an artificial intelligence (AI) model can help doctors better detect, diagnose, and treat esophageal cancer. Researchers will feed de-identified data from 12,000 patients receiving routine care into the AI and compare its recommendations to standard …
Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
10 years after ACL surgery: researchers use MRI to peek inside knees for early arthritis clues
Knowledge-focused By invitation onlyThis study looks at 219 people who had ACL reconstruction surgery about 10 years ago. Researchers will use MRI scans to check the health of the knee cartilage and compare it to the uninjured knee. The goal is to learn more about how osteoarthritis develops after a knee injury.
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Blood tests could spot hidden liver risk in diabetics
Knowledge-focused OngoingThis completed study observed 40 people with type 2 diabetes to find blood markers that could identify those at risk for a serious liver condition called NASH. Researchers measured liver stiffness and calculated scores like FIB-4 and ELF to see which patients might have liver sca…
Sponsor: Faculty Hospital Kralovske Vinohrady • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can a radioactive tracer reveal hidden lung scarring?
Knowledge-focused OngoingThis study tests whether a radioactive tracer called 68Ga-FAPi-46 can light up areas of scarring (fibrosis) in the lungs of people with interstitial lung disease. Participants receive the tracer and undergo a PET/CT scan to see where it collects. The goal is to understand how the…
Early phase 1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can we finally outsmart recurrent yeast infections? a new study investigates
Knowledge-focused OngoingThis study aims to understand why some women get recurrent vaginal yeast infections (vulvovaginal candidiasis) and others don't. Researchers will compare the vaginal microbiome, immune markers, and metabolic profiles of women with and without the infection. By identifying key dif…
Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Ear zap for IBD? tiny study tests nerve stimulation for gut relief
Knowledge-focused By invitation onlyThis pilot study tests whether daily, at-home stimulation of a nerve in the ear can change brain activity in people with inflammatory bowel disease (IBD) who are in remission. Fifteen adults with Crohn's disease or ulcerative colitis will use a small device for 28 days and underg…
Early phase 1 • Sponsor: University of Gdansk • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
A simple hospital checklist could flag hidden malnutrition in kids with IBD
Knowledge-focused OngoingThis study tests whether a standard nutrition screening tool, called PYMS, can accurately identify children with Crohn's disease or ulcerative colitis who are at risk of malnutrition. Researchers will use the tool on 2,000 children aged 4–18 with IBD in outpatient and inpatient c…
Sponsor: University of Glasgow • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
A simple test could forecast kidney disease progression
Knowledge-focused OngoingThis observational study explores whether levels of a protein called soluble CD163 in blood or urine can reflect how active IgA nephropathy is and how it might progress. Researchers will compare these levels among people with IgA nephropathy, those with a similar kidney condition…
Sponsor: Bezmialem Vakif University • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can a biologic drug tame juvenile arthritis in kids?
Knowledge-focused CancelledThis study follows children aged 6 to 17 with active juvenile enthesitis-related or psoriatic arthritis who are being treated with secukinumab. Researchers will track how long children stay on the drug, how much their symptoms improve, and whether they achieve remission. The goal…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Real-World dupixent: does it live up to the hype for eczema?
Knowledge-focused OngoingThis study follows about 955 people aged 12 and older who are starting treatment with Dupixent (dupilumab) for atopic dermatitis, commonly known as eczema. The goal is to see how the drug performs in everyday clinical practice, not just in controlled trials. Researchers will trac…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Mystery of persistent swallowing trouble in treated eosinophilic esophagitis explored
Knowledge-focused By invitation onlyThis study looks at people with eosinophilic esophagitis whose symptoms like trouble swallowing or chest pain continue even though their inflammation is under control. Researchers will use special tools to measure how stretchy the esophagus is and how it moves, and also consider …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Stool test may predict gut healing in ulcerative colitis
Knowledge-focused By invitation onlyThis study is testing whether a simple stool test can predict if the gut lining is healing in people with moderate-to-severe ulcerative colitis who are starting biologic therapy for the first time. Researchers will measure levels of a protein called calprotectin in stool samples …
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Could your genes raise your risk of heart muscle inflammation?
Knowledge-focused OngoingThis study examines genetic test results from over 600 people who had acute myocarditis (heart muscle inflammation) confirmed by MRI. Researchers want to find out how common certain gene variants are in this group and whether they are linked to worse outcomes like heart failure o…
Sponsor: French Cardiology Society • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Immune cell study could unlock new COVID-19 treatments
Knowledge-focused CancelledThis study looks at specific immune cells called myeloid cells in people who were hospitalized with COVID-19 pneumonia. Researchers want to understand how these cells respond to the virus and whether certain cell types can predict how sick a person gets. The goal is to find new w…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Simple tests could revolutionize chronic pain diagnosis
Knowledge-focused OngoingThis study aims to improve how doctors diagnose and treat chronic muscle and joint pain by using simple questionnaires and pain sensitivity tests. Researchers will study 250 adults with conditions like osteoarthritis, fibromyalgia, chronic low back pain, or inflammatory arthritis…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Can better school toilets and peer support boost girls' health and grades? a madagascar trial aims to find out.
Knowledge-focused By invitation onlyThis study in 140 rural secondary schools in Madagascar tests which parts of a hygiene program — new latrines and handwashing stations, peer-led sensitization, or free sanitary pad vouchers — most improve adolescent girls' learning, stress, and physical health. Researchers will m…
Sponsor: University of California Santa Cruz • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Study aims to keep workers with chronic illnesses on the job
Knowledge-focused OngoingThis study looks at how chronic noncommunicable diseases like inflammatory bowel disease and breast cancer impact a person's ability to work. Researchers will follow 200 working-age adults for 12 months, collecting data on health, work performance, and well-being. The goal is to …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
New brain scanner could reveal hidden effects of childhood neurological diseases
Knowledge-focused OngoingThis study uses a new, child-friendly brain imaging technique called OPM-MEG to understand how immune-related brain diseases (like autoimmune encephalitis and multiple sclerosis) and other brain conditions affect children aged 2 to 25. Standard scans often miss problems with memo…
Sponsor: Aston University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Digital diary aims to decode painful flares in spine condition
Knowledge-focused OngoingThis study investigates how people with axial spondyloarthritis (axSpA) experience sudden worsening of symptoms, known as flares. Over 12 months, 40 participants use a digital diary to track symptoms, diet, lifestyle, and self-management strategies, and provide blood samples duri…
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
22,000 patients studied to unlock secrets of deadly heart infection
Knowledge-focused OngoingThis observational study looks back at 22,000 adults in Sweden diagnosed with infective endocarditis, a serious heart valve infection, since 1997. By linking national health records, researchers aim to understand which patients benefit most from valve surgery and what factors aff…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists hunt for clues in the blood to predict lung fibrosis outcomes
Knowledge-focused By invitation onlyThis study looks for biological markers in blood and lung samples from people with idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. The goal is to find markers that can predict how the disease will progress and to group patients into subtypes. Researchers…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists probe immune cell exhaustion in hepatitis b
Knowledge-focused OngoingThis study looks at how chronic hepatitis B virus (HBV) infection affects natural killer (NK) cells, which are key immune cells that fight infections. Researchers will collect blood samples from 80 people with HBV and compare them to healthy donors. The goal is to understand why …
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Real-World study tracks elidel use in asian kids with eczema
Knowledge-focused OngoingThis study is observing how Elidel cream (pimecrolimus) is actually used in South and East Asian children aged 3 months to 12 years with mild to moderate atopic dermatitis (eczema). Researchers are tracking changes in eczema severity, itching, and sleep loss over the treatment pe…
Sponsor: BGP Products Operations GmbH, a Viatris company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Simple blood test may spot hidden liver trouble in colitis patients
Knowledge-focused By invitation onlyThis study looks at whether two blood markers, zonulin and LBP, can help detect liver damage in people with both ulcerative colitis (UC) and fatty liver disease. Researchers will measure these markers and use a special ultrasound to check liver stiffness in 100 adults with UC who…
Sponsor: University Hospital Dubrava • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Hepatitis b breakthrough? study checks if bepirovirsen response lasts
Knowledge-focused OngoingThis study follows about 360 people with chronic hepatitis B who had a good response to the experimental drug bepirovirsen in earlier trials. No new drug is given; researchers simply monitor whether the response lasts over time. Participants may or may not continue standard antiv…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Scientists probe immune secrets of four skin diseases
Knowledge-focused By invitation onlyThis study aims to understand inflammation in four chronic skin conditions: vitiligo, psoriasis, eczema (atopic dermatitis), and alopecia areata. Researchers will collect blood and small skin samples from 450 adults to analyze immune cells called T-cells. The goal is to describe …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Study aims to see if patient diaries match insurance data
Knowledge-focused CancelledThis study was designed to see how accurately patients report their own medication and healthcare use in diaries compared to official health insurance records. It planned to include people with diabetes, arthritis, kidney disease, or prostate cancer. However, the study was withdr…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for clues to predict blistering disease severity
Knowledge-focused OngoingThis study looks at 50 people with bullous pemphigoid, a skin condition that causes blisters. Researchers want to see if certain proteins in skin samples and blood markers like IgE and eosinophil counts are linked to how severe the disease is. The goal is to find better ways to m…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Knee X-Ray study pulled before starting
Knowledge-focused CancelledThis study was designed to see if X-rays taken before knee replacement surgery could reliably show ligament damage in people with knee arthritis. It was an observational study, meaning no treatment was given. However, the study was withdrawn before enrolling any participants, so …
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingThis study aims to create a tool that predicts which patients with inflammatory rheumatic diseases (like rheumatoid arthritis, vasculitis, or polymyalgia rheumatica) will develop serious side effects from long-term steroid use. Researchers will collect routine medical data—such a…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Gut check: 4,000-Person study links diet, genes, and stomach troubles
Knowledge-focused By invitation onlyThis study looks at how diet, genetics, and gut bacteria work together to cause digestive problems like IBS, IBD, and celiac disease. Researchers will follow about 4,000 adults with and without these conditions to find patterns. The goal is to understand why some people get sick …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists hunt for genes behind kidney disease
Knowledge-focused OngoingThis study aims to find the genetic causes of kidney diseases like FSGS and nephrotic syndrome. Researchers will collect saliva and urine samples from up to 2,050 participants, including patients and their family members, as well as healthy volunteers. The goal is to understand w…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Massive italian MS registry aims to unlock secrets of the disease
Knowledge-focused By invitation onlyThis observational study is creating a large database of up to 96,000 people with multiple sclerosis and related conditions in Italy. Researchers will collect information on patient demographics, treatments, and disease progression over time. The goal is to better understand thes…
Sponsor: Fondazione Italiana Sclerosi Multipla • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
300 kids with EoE enrolled in landmark database study
Knowledge-focused OngoingThis study gathers information from 300 children with eosinophilic esophagitis (EoE), a chronic allergic condition that inflames the esophagus. Researchers aim to better understand what causes EoE, how it relates to other allergies, and which treatments work best. No new treatmen…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Knee replacement recovery study pulled before it began
Knowledge-focused CancelledThis study aimed to test different regional anesthesia techniques to help people recover faster and go home sooner after total knee replacement. It planned to compare a standard pain injection with an added nerve block or continuous nerve block infusion. However, the study was wi…
Phase 4 • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Scientists track drug behavior in severe colitis patients
Knowledge-focused OngoingThis study looks at how the drug infliximab behaves in the body of people hospitalized with severe ulcerative colitis. Researchers measure drug levels in blood, stool, and colon tissue, along with changes in proteins and genes. The goal is to better understand how the drug works,…
Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Veteran peers lead fight against opioid overdose
Knowledge-focused OngoingThis study tests a program where veteran peer workers provide education, healthcare navigation, and social support to 150 veterans with opioid use disorder who are not connected to VA healthcare. The goal is to reduce risky behaviors related to overdose and HIV/HCV infection. Res…
Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New study to track severe joint infections in ICU patients
Knowledge-focused PausedThis study looks at patients in intensive care who have an infection in a joint replacement (like a hip or knee). Researchers want to understand their care path, recovery, and survival over two years. The study will collect data from medical records and phone calls with patients …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New database aims to speed up FMT research for gut infections
Knowledge-focused PausedThis study screens adults interested in fecal microbiota transplant (FMT) for Clostridium difficile infection. Researchers will collect medical information and run basic health tests to create a database of potential participants. The goal is to make it faster and easier to enrol…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Brain scans may predict who gets long-term pain from arthritis
Knowledge-focused OngoingThis study looks at why some people with early rheumatoid arthritis develop long-lasting chronic pain while others do not. Researchers will use pain sensitivity tests and brain scans to find clues. The goal is to better understand the transition from acute to chronic pain, which …
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Withdrawn study sought to understand sinus problems in young cancer survivors
Knowledge-focused CancelledThis study aimed to find out how often chronic sinusitis occurs in children treated for head and neck cancer, and how it affects their quality of life. Researchers planned to compare these children to those treated for cancer elsewhere in the body using a questionnaire called SNO…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Kidney transplant patients' immune response to common virus tracked after drug switch
Knowledge-focused OngoingThis study follows 28 kidney transplant recipients who are switching from one anti-rejection drug (anticalcineurin) to another (belatacept). Researchers want to see how this change affects the immune system's ability to fight the common CMV virus. Participants will have blood tes…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Eczema drug study pulled before it started
Knowledge-focused CancelledThis study was designed to see how well JAK inhibitors work for adults with moderate-to-severe eczema in real-world settings. It planned to track skin improvement, itching, sleep, and side effects. However, the study was withdrawn before enrolling any participants, so no results …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Researchers hunt for clues: do our own antibodies harm nerves?
Knowledge-focused By invitation onlyThis study looks at whether the immune system mistakenly makes antibodies that attack the body's own nerves and muscles in people with multiple sclerosis, myasthenia gravis, and similar conditions. Researchers will collect blood samples (and sometimes cheek swabs) from 120 adults…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Does an extra knee ligament procedure lead to arthritis later?
Knowledge-focused By invitation onlyThis study follows 510 people who had ACL knee reconstruction surgery, with or without an extra procedure called LET, about 10 years ago. Researchers want to see if adding LET increases the chance of developing knee osteoarthritis. Participants will get X-rays and answer question…
Sponsor: Western University, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New study aims to unlock secrets of pneumonia in the elderly
Knowledge-focused By invitation onlyThis study looks at 500 elderly patients (65 and older) with severe pneumonia to understand why some recover and others don't. Researchers will review medical records from hospitals across Europe, focusing on death rates and complications. No new drugs or treatments are being tes…
Sponsor: Joan Sabater-Riera • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Can mushroom and apple compounds boost your immune system?
Knowledge-focused OngoingThis pilot study is testing whether two natural dietary supplements—taxifolin (found in apples and onions) and ergothioneine (found in mushrooms)—can improve immune function in healthy adults aged 50 to 65. Researchers will measure how well immune cells engulf and destroy threats…
Sponsor: University of Southampton • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Scientists examine gum tissue to improve periodontal healing predictions
Knowledge-focused By invitation onlyThis study looks at tissue samples taken from deep gum pockets in people with periodontitis who have already completed initial treatment. Researchers want to describe the tissue features and see if they relate to how well the gums heal. The goal is to better understand healing pa…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Prenatal pollution linked to baby eczema?
Knowledge-focused OngoingThis study follows 456 mothers and their children for 5 years to see if certain chemicals in the mother's blood during pregnancy are linked to the child developing eczema. Researchers will check children's skin regularly and track any eczema diagnosis. The goal is to understand p…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Lung disease study probes hidden environmental triggers
Knowledge-focused OngoingThis study looks at how things in the environment and at work might affect people with interstitial lung diseases (a group of lung conditions). Researchers will ask 1,000 adults with a new diagnosis about their exposures to things like pollution, chemicals, and dust. The goal is …
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Gene study aims to unlock secrets of progressive lung disease
Knowledge-focused OngoingThis study follows 250 Italian adults with genetic forms of pulmonary fibrosis to see how their lung function changes over time. Researchers will track breathing tests and compare patients who receive immune-modulating drugs with those who do not. The goal is to understand how in…
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Gum disease bacteria showdown: new study targets hidden culprits
Knowledge-focused By invitation onlyThis study compares the levels of two bacteria, E. saphenum and P. gingivalis, in 148 adults over age 30—111 with gum disease (periodontitis) and 37 with healthy gums. Researchers collect plaque samples and use advanced lab tests to measure bacterial levels. The goal is to better…
Sponsor: Sarah Al-Rihaymee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Heart fix may heal your gut, new study hints
Knowledge-focused OngoingThis study looks at how a common heart valve procedure called TAVI changes the gut microbiome in older adults with aortic stenosis. Researchers will collect blood and stool samples before and three months after TAVI to measure bacterial byproducts and diversity. The goal is to se…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny study peers inside finger joints to unlock RA bone erosion secrets
Knowledge-focused OngoingThis study looks at bone erosions in the finger joints of 9 people with rheumatoid arthritis. Researchers use advanced imaging and tissue analysis to see tiny blood vessels and bone structure. The goal is to better understand how joint damage happens, which could lead to better m…
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Researchers watch how clot removal affects leg vein valves
Knowledge-focused By invitation onlyThis study follows 100 people with acute deep vein thrombosis in the leg to see how well their vein valves work one year after a clot removal procedure. Participants receive standard care, including a device to remove the clot and blood-thinning medication. The goal is to learn w…
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Scientists dig into the vaginal microbiome to unlock secrets of recurrent yeast infections
Knowledge-focused OngoingThis study looks at 120 Canadian women to understand why some get repeated yeast infections while others don't. Researchers will compare the vaginal yeast and bacteria of women with their first infection, those with recurrent infections, and those with yeast but no symptoms. Part…
Early phase 1 • Sponsor: University of Manitoba • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
10-Year tooth retention study: does this dental sealer deliver?
Knowledge-focused OngoingThis study checks how many teeth remain functional 10 years after root canal treatment using a sealer called Endomethasone N. Researchers will review records from 179 adults who had the treatment at least 5 years ago. The goal is to understand the long-term success and safety of …
Sponsor: Septodont • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Prison hepatitis c study pulled before it began
Knowledge-focused CancelledThis study planned to see if faster testing and treatment for hepatitis C could be given to inmates right when they enter prison. The goal was to start medication sooner to reduce the spread of the virus. However, the study was withdrawn and no one took part.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to uncover hidden cancer clues in autoimmune disease
Knowledge-focused OngoingThis study examines blood samples from 50 people with dermatomyositis, an autoimmune disease that raises the risk of cancer. Researchers are looking for new antibodies and immune molecules that might signal which patients are more likely to develop cancer. The goal is to improve …
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Knee replacement showdown canceled before it started
Knowledge-focused CancelledThis study aimed to compare knee movement in people who had one of two different total knee replacements. Researchers planned to measure how the knee bends and shifts during activities like stepping up and deep knee bends. The study was withdrawn before any participants were enro…
Sponsor: The University of Tennessee, Knoxville • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Massive italian study aims to uncover what really affects COPD survival
Knowledge-focused By invitation onlyThis large real-world study will follow 10,000 Italian patients with COPD to see how their treatments, flare-ups, and other health conditions affect their risk of death. Researchers will collect data on medications, lung function, and heart problems over time. The goal is to bett…
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Gum disease treatment may alter Bone-Related markers, study finds
Knowledge-focused OngoingThis study looks at how a standard deep-cleaning procedure called scaling and root planing affects certain proteins in the blood and gum fluid of people with advanced gum disease. Researchers will compare 28 patients with stage 3 periodontitis to 28 healthy individuals, measuring…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Heart scans after COVID shot: new study aims to uncover hidden risks
Knowledge-focused OngoingThis study looks at 57 people who received a COVID-19 vaccine to understand why some develop heart injury or myocarditis. Researchers use advanced heart scans (PET/MRI) and blood tests to find early warning signs. The goal is to better identify those at risk and improve follow-up…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Spine surgery showdown: robot vs. Surgeon's hand
Knowledge-focused OngoingThis study compares robot-assisted spine surgery to the traditional method in 300 adults needing spinal fusion. The goal is to see if the robot helps place screws more accurately, reduces complications, and improves patient outcomes. Participants are randomly assigned to either r…
Sponsor: Elsan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Gum nicotine levels may predict periodontitis treatment success
Knowledge-focused By invitation onlyThis study examines how nicotine buildup in gum tissue influences the results of non-surgical periodontitis treatment. Researchers will measure nicotine and cotinine levels in the gums of 56 smokers and non-smokers with periodontitis. The goal is to understand if nicotine intoxic…
Sponsor: University of Liege • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study sheds light on thyroid disease in kids under 6
Knowledge-focused By invitation onlyThis study examines autoimmune hyperthyroidism in children diagnosed before age 6, focusing on their symptoms, growth, and response to treatment. Researchers will compare these young children with older children who have the same condition. The goal is to identify patterns that c…
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Hip implant under the microscope: 5-Year safety study launched
Knowledge-focused OngoingThis study is tracking 120 people who received a HYPE SCS hip stem during total hip replacement. Researchers will monitor how long the implant lasts, how satisfied patients are, and any complications over 5 years. The goal is to confirm the device is safe and works as intended in…
Sponsor: Societe dEtude, de Recherche et de Fabrication • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Gum Disease's hidden toll: new study links severity to quality of life
Knowledge-focused OngoingThis study looks at how the severity of gum disease (periodontitis) impacts people's daily lives. Researchers examined 300 adults aged 18 to 65, measuring gum health through clinical exams and using two short questionnaires (OHIP-14 and OShip-14) to capture how oral health affect…
Sponsor: Abant Izzet Baysal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study digs into how mepolizumab changes nose bacteria and genes in asthma patients
Knowledge-focused OngoingThis study tracks 40 people with nasal polyps and severe asthma who are taking mepolizumab, a drug that reduces inflammation. Researchers collect nose, blood, and sputum samples before treatment and at 3, 6, and 12 months to see how the drug affects symptoms, nose bacteria, and g…
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Wire wars: which guide wire is safer for pancreas procedures?
Knowledge-focused PausedThis study compares two types of guide wires (short vs long) used during a procedure called ERCP, which helps doctors examine the bile and pancreatic ducts. The goal is to see which wire allows faster and safer cannulation (insertion of a tube) and whether either reduces the risk…
Sponsor: Niguarda Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Blood test may predict lung decline in rare disease
Knowledge-focused OngoingThis study is looking for markers in the blood that can predict whether a person's chronic hypersensitivity pneumonitis will get worse over time. Researchers will follow about 137 patients at 7 U.S. centers for 24 months, tracking lung function, symptoms, and CT scans. The goal i…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Athletes' hearts under watch: new study tracks rhythm risks after myocarditis
Knowledge-focused OngoingThis study follows 50 athletes who had acute myocarditis (heart muscle inflammation) to see how often they develop dangerous heart rhythms. Participants wear a portable ECG monitor and do a treadmill stress test at 3 months and 1 year after their illness. The goal is to learn mor…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Rare disease pregnancy study pulled before it began
Knowledge-focused CancelledThis study was designed to track pregnancies in women with rare autoimmune and systemic diseases to understand complications and improve care. It planned to enroll women with conditions like lupus, rheumatoid arthritis, and scleroderma. However, the study was withdrawn before any…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Major study aims to spare patients painful liver biopsies
Knowledge-focused By invitation onlyThis study follows 1,689 adults with fatty liver disease (MASLD) or MASLD with increased alcohol intake (MetALD) to see if non-invasive tests like MRI and Fibroscan can accurately track disease progression. The goal is to reduce the need for liver biopsies in future research and …
Sponsor: HRI-MAIL-NIT • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New study aims to find safe scabies treatment for toddlers
Knowledge-focused OngoingThis study looks at how well a single dose of ivermectin works in children under 5 with scabies. Researchers want to make sure the dose is safe and effective for this age group. About 120 children in Laos will take part, and the study will measure drug levels in the blood.
Phase 2 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New protocol aims to speed up pancreatitis recovery
Knowledge-focused OngoingThis study looks at whether a standard set of guidelines, called the Methodist Acute Pancreatitis Protocol (MAPP), improves care for people with acute pancreatitis. Researchers will compare outcomes like hospital stay length and discharge status before and after the protocol was …
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Inside the ICU: new study tracks tough pneumonia cases
Knowledge-focused OngoingThis study follows 100 adults hospitalized in intensive care units with severe pneumonia caused by Mycoplasma or Chlamydia bacteria. Researchers will track how patients are treated, how long they stay in the hospital, and how many survive. They will also check for antibiotic resi…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Scratching the surface: study explores skin Irritation's role in psoriasis
Knowledge-focused CancelledThis study aimed to understand why psoriasis and lichen planus often appear on skin that is rubbed or irritated, like from tight clothing. Researchers planned to irritate a small patch of skin in people with these conditions and healthy volunteers, then take skin samples to study…
Sponsor: Marie-Charlotte Brüggen • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can a simple conversation tool boost surgery satisfaction for arthritis patients?
Knowledge-focused OngoingThis study looks at whether using a patient decision aid during doctor visits helps people with severe hip or knee osteoarthritis make better choices about surgery. Researchers will track how informed patients feel, their involvement in decisions, and their pain, function, and qu…
Sponsor: Vejle Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Knee replacement showdown: which design lets you move best?
Knowledge-focused OngoingThis study looks at three different knee replacement designs: one that keeps the ACL, one that substitutes for it, and one that sacrifices it. Researchers want to see which design gives the best function, pain relief, and satisfaction in 75 people with severe knee arthritis. Part…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Knee replacement patients: what really gets you back to work?
Knowledge-focused OngoingThis study follows 88 working-age adults (63 or younger) who had knee replacement surgery to see when and how many return to work. Researchers track pain, knee function, and work ability using questionnaires over 1.5 years. The goal is to identify factors that help or hinder retu…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC